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ABSTRACT 
 
EXPLORING THE WORLD OF HELIX ASSOCIATION: 
DISEASE MECHANISM, BASIC FOLDING AND NOVEL DESIGN  
Yao Zhang 
William F. DeGrado, Thesis Advisor 
 
Helix association provides an efficient model for studying the fundamental 
principles behind protein folding. It also serves as a suitable template for the design of 
proteins with novel functions. This thesis begins by investigating the role of 
transmembrane helix association in protein folding, where a novel “protein-folding-
centric” viral fusion model has been proposed here to explain the membrane-fusion 
process of paramyxovirus. Furthermore, the forces driving membrane helix association, 
which determine both affinity and orientation, have been quantitatively studied using a 
model membrane peptide MS1. Finally, two examples are discussed that illustrate the 
application of helix association in novel protein design. A pH-switchable drug delivery 
system for the endosomal escape of biomacromolecular therapeutics has been designed 
using the helix-association model. The sequence is designed to form a stable water-
soluble helix bundle at pH 7.4 and to insert in membrane at lower pH to promote 
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endosomal escape. The most successful sequence shows selective release for 
biomacromolecule (ATP and miRNA) at lower pH (pH 5.4). The assembly of the 
designed peptide has been studied in aqueous buffer, detergent micelle and model lipid 
bilayer using the most successful sequence. Also, the paradigm of helix association has 
been applied to the design of a membrane metalloprotein, which can serve as a template 
for further design of membrane metalloenzymes. In summary, the work in this thesis has 
established an efficient model for helix association that can be used to solve problems in 
both basic and applied research. 
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1 
 
1 Chapter 1: Introduction: The fundamentals of protein 
folding and the model of helix association 
 
1.1 The significance of protein folding 
Proteins carry out vital functions in every living creature.
1
 The proper folding of 
proteins into their specific three-dimensional structures is the only way that the correct 
function can be achieved.
1
 The ability to interpret the relationship between the primary 
sequence of protein and its folding will not only help understand the pathology of protein 
misfolding-related diseases such as Alzheimer‟s,2 cystic fibrosis,3 and prions disease;4 but 
also create new functions such as novel enzymes, biomaterials and delivery agents. After 
decades of effort, protein folding is subject to the attentions of multiple disciplines, such 
as biology, chemistry, physics, mathematics, and engineering; and is one of the most 
fundamental processes studied by science. 
 
While the mechanism of protein folding is complicated, the final folded status, 
including secondary, tertiary and quaternary structure, is simply determined by the 
primary sequence of a protein.
5
 Nevertheless, the process that translates from sequence to 
the final folded structure is still mysterious.  One strategy to investigate this mystery is to 
identify the sequence motif that determines specific interactions. With the golden rules 
identified, we can predict unknown protein structures/functions, also design novel 
protein-based functions, which are two major goals in the field of protein folding research. 
2 
 
1.2 The impediments to studying protein folding  
The major challenge in the field of protein folding originates from the complexity 
of the systems that proteins are involved in. The major contributors to this complexity 
would be folding hierarchy, environmental factors, and folding dynamics.  
 
Folding takes multiple steps. It has been proposed that the sequence first searches 
into a specific secondary structures, such as alpha-helix, beta-sheet, etc.
6
 Then the single 
chain further forms tertiary structures driven by forces such as local hydrophobic 
interaction, hydrogen-bond formation and ligand binding.
7
 Sometimes in order to obtain a 
more advanced function, a group of tertiary structures need to interact with each other 
and further form quaternary structures.
7
 
 
Secondly, the sequence of amino acids alone usually does not completely 
determine the folding pathway, although it determines the final fold. Environmental 
factors such as pH,
8
 ligand binding,
9
 thermal changes,
10
 energy transfer,
11
 etc., frequently 
play key roles which triggers/assists the folding and also add to the variables in the 
equation of folding.  
 
A third hurdle to understanding protein folding comes from the dynamics of the 
folding process itself. Regardless of reaching equilibrium or not, the system usually 
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involves transitions among multiple components in a dynamic way.
12
 Taking the 
dynamics into consideration, the system becomes even more complex and mysterious.  
 
Facing the complexity of the protein folding systems, a simplified model is called 
for, which should allow us to study the key problems in a detailed manner in a 
manageable system and also serve as a scaffold to design more advanced systems. 
 
1.3 The helix-association-based model for studying protein folding 
Helix association is the major part of the model of peptide interaction. Statistics 
suggests that the predominant structural motif in proteins is alpha-helix in both aqueous 
and membrane systems.
7
 The association of helices is a major part of protein folding and 
is thermodynamically linked to protein folding. Helix association has been widely used as 
a model to study protein folding because helix association sufficiently represents the key 
steps for protein folding in most cases and it also significantly simplifies the system. 
 
In terms of sufficient representatives, successful examples of helix association 
have been developed in the field of disease mechanism exploration, such as the six-helix 
coiled coil in HIV gp41,
13
 the tetramer M2 proton transporter in influenza virus,
14
 and the  
heterotetramer in SNARE complex.
15
 Most importantly, inhibitors designed upon these 
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segment has successfully blocked folding,
16
 supporting their uses as sufficient 
representatives.  
 
Helix association model is also simplified by the relatively short length of the 
studied peptides. Compared to proteins with more than a few hundred residues, a 20-50 
residue peptide (helix) is often relatively easier in its synthesis, purification and assay 
development, which allows more advanced experimental study. This short length also 
saves cost for computational modeling/simulation, both in terms of coding time and 
calculation circles. Altogether, peptides (helix) have been considered as a practical model 
for studying protein folding. 
 
1.4 The coiled-coil model 
Coiled-coil helix interactions are one of the most studied types of helix 
interactions. Coiled coils represent a ubiquitous and important structural motif in helices 
and also in proteins, with 10% estimated population in proteins. 
17
 
 
In coiled coils two to seven alpha helices coil with each other into a strand of 
rope.
18
 Usually this super-twist is left-handed. Because of the geometry of the left-handed 
coiled coil, the orientation of the amino acids repeats every seven residues with respect to 
the protein interface. That is why coiled coils are characterized by a so called heptad 
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repeat in their primary sequences (abcdefg)n,
19, 20
 in which the a and d positions are 
presented at the interface and play essential roles for bringing helix association (Figure 1).  
A 
 
 
B  
 
Figure 1.1 A schematic coiled coil heptad repeat for a parallel dimer (A) and a parallel 
heptamer (B) The schematic map is made via program DrawCoil 1.0, developed by Dr. 
Gevorg Grigoryan (http://www.gevorggrigoryan.com/drawcoil/). 
 
One of the most studied left-handed coiled coils is the water-soluble parallel 
dimer GCN4-p1, the coiled-coil domain of the yeast transcription activator GCN4.
21
 
Mutations in GCN4-p1 can derive coiled coil variants that are trimers or tetramers,
22, 23
 
and parallel or anti-parallel,
24
 which will be discussed later in the introduction. Recently a 
de novo designed left-handed parallel seven-helix coiled coil has been characterized with 
the 1.25 Å crystal structure, which reveals a large tubular channel in the interior.
25
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Like left handed coiled-coils, right-handed coiled coils have also been discussed 
in both natural and designed system, such as a parallel tetramer with 11-residue repeats 
from the surface layer of the protein tetrabrachion
26
 and a parallel tetramer with 15-
residue repeats from human vasodilator-stimulated phosphoprotein (VASP).
27
 These 
right-handed coiled coils represent the versatility of the coiled coil and play important 
roles in biological functions and design purposes.  
 
Coiled coils have been extensively studied in the past few decades. The 
accumulated information and regularity of from coiled coil make them a preferred model 
system for study/design of helix association. In the following part of the introduction, 
case studies will illustrate the application of the coiled-coil model in research of both 
aqueous (water-soluble) system and membrane system. 
 
1.5 Case study of GCN4-p1: the folding in an aqueous system 
GCN4-p1 is a parallel, left-handed water-soluble homodimer. Crystal structure 
suggests that GCN4-p1 adopts a coiled-coil conformation, with the side chains in the 
interface packing into the classical “knob-into-holes” model.28  As seen in the sequence 
of the primary coiled coil region, four leucines are aligned as a twisted ladder along the a 
position of the helix, forming the canonical “leucine zipper” and promoting dimerization 
(Figure 1.2). This leucine zipper echoes nicely with the previous research that 
hydrophobic interaction is the driving force for water-soluble protein folding. 
29, 30
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A.     Peptide   abcdefg abcdefg abcdefg abcdefg abcdefg 
GCN4-P1   MKQLEDK VEELLSK NYHLENE VARLKKL VGER 
B. 
 
Figure 1.2 The sequence and sketch map of heptad repeat for GCN4-p1. The schematic 
map is made via program DrawCoil 1.0 
 
Not limited in GCN4-p1, on average 80% of the a and d position in natural water-
soluble coiled coils are occupied by apolar residues.
31
 Also, inserting unnatural amino 
acids with stronger hydrophobicity, such as trifluoroleucine or trifluorovaline, leads to 
higher stability for coiled coils.
32, 33
 
Hydrophobic interactions not only affect coiled coils‟ stability, but also determine 
their specificity. A series of mutational studies have been done with GCN4-p1. The 
coiled coil stays as a dimer with “I” and “L” in a and d positions respectively; it becomes 
a trimer with “I” in both a and d positions; and it is turned into tetramer with “L” and “I” 
in a and d positions respectively.
22, 23
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Hydrogen bonding is another major force driving the folding of coiled coils in 
aqueous systems. The polar residues in the core positions play a key role in determining 
specificity, supported by the fact that polar residues comprise 20% population of all the 
residues in the a and d positions of natural coiled coils.
31
 If the asparagine in the a 
position in GCN4-p1 is altered into a valine, the stability of the coiled increases due to 
the increase in hydrophobic packing, however, the predominance of dimeric form 
disappears.
34
 
 
Ionic interaction between the e and g´, as well as e´ and g (Figure 1.2B) , also 
plays important roles in determining the stability and specificity for left-handed coiled 
coils, which are defined as the canonical i to i+5 salt bridge in heptad-repeat systems.
20
 
As shown in Figure 1.2, in GCN4-p1 the glutamic acid and lysine, in the e and g´, as well 
as e´ and g positions respectively, form a favorable salt bridge and stabilize the 
homodimer. The formation of a salt bridge highly depends on sequence, space, geometric 
preferences and environment factors.
35
 For example, the salt bridge contributes about 1 to 
2 kJ/mol to coiled coil stability, depending on salt concentration.
36-39
  
 
Interestingly, replacing the charged residue in e or g positions with apolar 
residues results in an anti-parallel tetramer,
40
 while replacing both the charged residues in 
e and g positions with the small apolar residue alanine results in a parallel seven helix-
coiled coil.
25
 This discloses the importance of packing at the e and g positions for water-
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soluble coiled coils, which apparently play very interesting roles in determining the 
specificity of coiled coil and deserves further exploration. 
 
Specificity regarding oligomerization has been discussed above. Many 
investigations into the specificity of interaction orientation have also been done in the 
past few decades. Since the majority of coiled coils appear to form parallel relative helix 
alignments in the earliest studies, the design of anti-parallel coiled coils or helix bundles 
has become an interesting current topic.
24
 The first reported de novo designed anti-
parallel coiled coil was restrained by an interior disulfide bond.
41, 42
 A major advance was 
when glutamic acid and lysine were engineered to interact only when the helices adopt an 
anti-parallel orientation in a heterodimer;
28
 and an asparagine pair in the adjacent helices 
was engineered to interact only when the helices adopt anti-parallel manner in 
homodimer.
43
  
 
The successful design of anti-parallel trimer coiled coils
44, 45
 and anti-parallel 
three-helix bundle
46
 are mainly based on the modification of the homotrimeric parallel 
coiled coil by the manipulating Coulomb interactions from charged residues. Also, 
tryptophan residues have been proposed to contribute to the formation of an antiparallel 
trimer since three indole sidechains would be poorly accommodated in a parallel coil.
44, 47
  
Moreover, effort has been made in modifying interactions between b and e position, as 
10 
 
well as g and c positions, as these interactions significantly contribute to the stabilization 
of anti-parallel four stranded coiled coil.
48
 
 
1.6 The application of coiled coil-based design in aqueous systems 
In recent decades, coiled-coil-based design has succeeded in diverse fields, thanks 
to the gradually accumulated knowledge of sequence-determined stability and specificity. 
Here I will highlight a few examples in aqueous systems.  
 
Biofuel cell cathodes have been designed based on a coiled coil dimer, taking 
advantage of a coiled-coil‟s physical self-assembly functionality.49 An antibody screening 
assay against HIV-1 has been designed based on the coiled-coil region of the transient 
viral entry intermediate (the prehairpin intermediate) formed by the HIV-1 gp41 
protein.
50
 A vaccine has been designed for prototypical Severe Acute Respiratory 
Syndrome (SARS), the design of which is based on the C-terminal coiled coil of the 
virus‟ spike protein.51  A novel protein fiber has been designed based on a leucine zipper 
coiled coil. This self-assembled coiled coil can super assemble into a fiber that measure 
about 45 nm across
52
 and could serve as a perfect scaffold for future tissue engineering.  
 
Computational calculations, modeling and simulation have boomed in the field of 
rational design. Nowadays scientists not only use computational programming to pack the 
11 
 
designed structure in order to achieve the sequence with the most stable target structure,
53, 
54
 but also utilize negative design to improve final specificity.
55
 
 
Undoubtedly, coiled coils provide efficient scaffolds for future design and present 
great potential for diverse applications.  
 
1.7 Understanding membrane protein folding with coiled-coil-based design 
As remarkable as the contribution the coiled-coil-based model has made to the 
aqueous system, it also has had great importance in the research of membrane protein 
systems.  
 
It is predicated that about 30% of all the genes encode for membrane proteins and 
60% of drugs in current market target membrane proteins.
56
 However, only 1% of 
structures in PDB database correspond to membrane proteins. The lack of knowledge 
about membrane proteins is mainly because of the difficulties associated with the relevant 
studies. From an experimental point of view, first of all most membrane proteins are hard 
to express, synthesize and purify compared to water-soluble proteins due to their high 
hydrophobicity. Secondly, membrane proteins have to be solubilized in the lipid bilayer 
or detergent during studies, thus some established assays in water-soluble systems can‟t 
be applied to the membrane target. Moreover, it is hard to find an assay which can create 
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a detectable thermodynamically reversible equilibrium for membrane protein folding. 
Computational modeling requires simulation of the lipid or detergent environment, which 
creates challenges in molecular dynamics simulations.   
 
Despite the difficulties of working with membrane proteins, significant progress 
has been made in the membrane field in the past decade. There are two major classes of 
structural motifs in membrane proteins: all-beta sheets and all-alpha helices. The proteins 
in cytoplasmic membranes are essentially all in the all-alpha class, whereas the outer 
membranes of bacteria and mitochondria also are rich in all-beta. However, most 
pharmacologically relevant membrane proteins are all-alpha helices therefore the 
majority of work on membrane protein has focused on the transmembrane (TM) helix.
57
  
 
In a well-accepted model, membrane helix association involves two kinetically 
separate steps: In the first step the TM helical region is inserted into lipid bilayer; in the 
second step the TM helices interact with each other and form bundles
57, 58
. This thesis 
will focus on the second step and explore the folding mechanism for membrane helix 
association and relative designs. 
 
Where the issue of folding is concerned, it is always required to identify an 
unfolded state and a folded state in the beginning of study. In our helix-association model, 
13 
 
the unfolded state would be the single helix which retains the helical secondary structure; 
and the folded state is the associated helix bundle.
59
 Mirroring the trajectory of water-
soluble systems, the coiled coil model has been widely used in understanding the driving 
force for membrane helix association and helix-association-based membrane protein 
design. This thesis will highlight the successful design and characterization of the model 
peptide MS1, a putative membrane coiled coil. 
 
1.8 Case study of MS1: folding in micelles and bilayers 
MS1 is designed based on the classic water-soluble coiled coil GCN4-p1. The 
design maintains the core residues in a and d positions of GCN4-1:
60
 “V” “N” “V” “V” 
in consecutive putative a positions and “L” in all the putative d positions (Figure 1.3). 
Fluorescence and sedimentation analytical ultracentrifugation assays suggest that MS1 
adopts an equilibrium of a monomer-dimer-trimer in detergent micelle N-tetradecyl-N,N 
dimethyl-3-ammonio-1-propanesulfonate (C-14 betaine). The maintained asparagine has 
been shown to play a crucial role in the self-association of MS1: the mutation of 
asparagine into valine (N14V) eliminates the ability to oligomerize.
60
 Mutation of 
asparagine into other polar residues with two polar atoms such as glutamine, aspartic acid 
and glutamic acid, retains the ability to form stable trimers, while the mutation of 
asparagine into polar residues with one polar atom such as serine and threonine, results in 
a much weaker tendency to associate.
61
 It is proposed that the inter-molecular hydrogen-
14 
 
bond network formed by the asparagine is the major driving forces for the helix-
trimerization in MS1. 
62
 
 
With MS1, the role of hydrophobic effect in membrane helix association has also 
been probed. The mutation L10A (Figure 1.3) probes how hydrophobicity in putative d 
positions affects that association of membrane helices. Interestingly this alteration does 
not change the oligomerization state. Moreover, the variant forms significantly tighter 
trimers than the wild type (by -0.5 kCal/mol monomer), which suggests that hydrophobic 
interactions are not the major driving forces for membrane helix association. Instead, 
small residues are preferred in the helical interface
60, 63
, which will be further discussed in 
Chapter 3.  
 
 
Figure 1.3 The sequence of MS1 and variants 
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A parallel project carried out at the same time also emphasizes the importance of 
polar residue in membrane helix association.  The TM part of this parallel design is also 
based on GCN-p1, which maintains the residues in the putative a position (VNVV) and 
replaced the rest of the residues with leucine. Thermodynamic studies with this design 
suggest that helix association is driven by the polar asparagines at the putative a position, 
independent of the rest of the hydrophobic leucine sequence in both detergent micelles 
and biological membranes.
64
 
 
The importance of polar residues in membrane protein folding also echoes the fact 
that mutations of the polar residues in membrane proteins are usually the most common 
disease initiators for membrane protein related diseases.
65, 66
 Interestingly, this important 
driving force in some cases is relatively modest. Using bacteriorhodopsin as the target 
systems, double-mutation cycle analysis suggests that the average contribution of the 
eight hydrogen-bonding interactions in bacteriorhodopsin is only about 0.6 kcal/mol. The 
authors proposes that this important while modest hydrogen-bonding might result from 
the geometry constrains or evolutionary pressures.
67, 68
     
 
1.9 Membrane structural motifs 
As the exploration of membrane protein extends, structural motifs/rules about 
membrane protein folding have gradually been revealed. Discovered in glycophorin A,
69-
74
 the GxxxG motif has been shown to drive membrane helix dimerization by promoting 
van der Waals interaction with an ideal geometric fit and weak Cα-H hydrogen-bonding. 
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Extensive mutagenesis studies suggest that the motif LIxxGVxxGVxxT is crucial for the 
dimerization of glycophorin A.
69, 70
  Further statistics suggests that this role of glycine 
can also be extended to other small residues such as alanine and serine. Therefore this 
motif has been updated to the [Sm]xxx[Sm] motif that drives TM helix association, 
where “[Sm]” here refers to small apolar residues.74   
 
As more crystallographic structures of membrane proteins are deposited to the 
PDB library, the analysis of the membrane helix interactions have been categorized into 
two groups.
75
 For the right-handed membrane helix interactions, GxxxG or [Sm]xxx[Sm] 
is the most popular structural motif. For the left-handed membrane helix interactions, 
small residues, such as glycine or serine, repeating in every seven residues, are 
commonly seen in the packing interface. Heptad repeats of serine, which is called a serine 
zipper, have been used to design anion channel peptide
76
 and an anti-parallel membrane 
helix bundle.
77
 Also, hydrogen bonds via polar residues are frequently found to mediate 
the association in left-handed membrane helices.
78
 
 
1.10 The application of sequence-based protein folding studies 
The ultimate goal of sequence-based folding studies is to predict the protein 
structure based on the primary sequence, and to design protein sequence which can obtain 
specific functions.  
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The accumulated understanding of membrane protein folding provides support for 
structural prediction of membrane proteins.
79-81
 The knowledge of first principles and 
prediction has also promoted the rational design of functional membrane proteins,  such 
as activator 
82
 for platelet integrins, a drug delivery agent,
83
 and a diporphyrin-binding 
TM electron transfer protein.
84
 In both prediction and design, computational calculation 
and modeling have played significant roles. Adding explicit terms and modeling realistic 
membrane phases has significantly increased the success rates of the designs.
80, 84
  More 
detailed examples will be discussed in the following chapters.  
1.11 The exploration of helix association in both aqueous and membrane systems 
This thesis focuses on the application of helix association in both fundamental and 
applied research, such as: discovering the role of helix interaction in diseases, especially 
viral fusion/entry (Chapter 2), exploring the driving forces for membrane helix 
association (Chapter 3), designing a pH-switchable helix-association based drug delivery 
agent (Chapter 4), and designing a membrane metal-binding four-helix bundle (Chapter 
5). 
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2 Chapter 2 Transmembrane Orientation and Possible Role 
of the Fusogenic Peptide from PIV5 Virus in Promoting 
Fusion 
 
2.1 Abstract 
Membrane fusion is required for diverse biological functions ranging from viral 
infection to neurotransmitter release. Fusogenic proteins increase the intrinsically slow 
rate of fusion by coupling energetically downhill conformational changes of the protein 
to kinetically unfavorable fusion of the membrane-phospholipid bilayers. Class I viral 
fusogenic proteins have an N-terminal hydrophobic fusion peptide (FP) domain, 
important for interaction with the target membrane, plus a C-terminal transmembrane (C-
term-TM) helical membrane anchor. The role of the water-soluble regions of fusogenic 
proteins has been extensively studied, but the contributions of the membrane-interacting 
FP and C-term-TM peptides are less well characterized. Typically, FPs are thought to 
bind to membranes at an angle that allows helix penetration but not traversal of the lipid 
bilayer. Here we show that the FP from the paramyxovirus PIV5 fusogenic protein, F, 
forms an N-terminal TM helix, which self-associates into a hexameric bundle. This FP 
also interacts strongly with the C-term-TM helix. Thus, the fusogenic F protein resembles 
SNARE proteins involved in vesicle fusion by having water-soluble coiled-coils that 
zipper during fusion and TM helices in both membranes. By analogy to mechanosensitive 
channels, the force associated with zippering of the water-soluble coiled coil domain is 
expected to lead to tilting of the FP helices, promoting interaction with the C-term-TM 
helices. The energetically unfavorable dehydration of lipid headgroups of opposing 
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bilayers is compensated by thermodynamically favorable interactions between the FP and 
C-term-TM helices as the coiled-coils zipper into the membrane phase, leading to a pore 
lined by both lipid and protein.  
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2.2 Introduction 
The basic mechanisms of viral membrane fusion have been studied extensively, 
but major gaps remain in our understanding of the relative roles of lipidic intermediates 
and viral fusogenic proteins in lowering the energy barrier for the overall process 
85-88
. 
The most common mechanistic hypothesis concerning enveloped viral fusion is that 
fusogenic proteins primarily serve to bring the target cell and viral membranes into 
proximity. Fusion occurs in a multi-step process, in which the virus first binds to a 
specific receptor; this event and/or other environmental cues then cause a conformational 
change in the protein, leading to a metastable state with an exposed hydrophobic fusion 
peptide (FP) that binds to the target membrane. Once engaged with the bilayer a second 
energetically favorable conformational change in the fusogenic protein then exerts a force 
pulling the FP towards the viral membrane, in effect reeling the host and viral membranes 
together. 
 
The conformational changes involved in the water-soluble portions of viral 
fusogenic proteins have been largely elucidated, but the roles of the membrane-binding 
FP and the C-terminal transmembrane (C-term-TM) anchor are less clear. After the 
crystal structure of the pre-fusogenic form of influenza hemagglutinin (HA) was solved 
89
, 
experimental studies suggested that its FP inserted into the bilayer 
90
. The FP helix was 
thought to bind sufficiently deeply to act as a hydrophobic wedge that not only served as 
an anchor but also destabilized the bilayer and facilitated fusion. Many biochemical, 
biophysical and mutagenesis studies on the fusion proteins of the influenza virus, HIV 
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and other viruses are consistent with, and have added considerable detail to, this initial 
suggestion 
91-118
. However, a number of intriguing findings suggest that the FPs and C-
term-TM helices might play additional, more specific, roles in bilayer fusion than mere 
membrane binding and disruption.  
 
Surprisingly subtle mutations in the C-term-TM sequence of fusogenic proteins 
can be quite deleterious to their ability to induce fusion, while retaining normal 
processing and the ability to change conformations 
119-122
. Also, replacing C-term-TM 
helices of fusogenic proteins with lipid anchors results in a loss of fusion 
123-126
 and, 
surprisingly, FP sequences often show greater conservation than might be expected from 
the functional requirements for membrane binding 
127
. Moreover, the very strong 
conservation of polar and small residues at regularly spaced intervals as found in 
GXXXG 
70, 74, 128
, glycine zippers 
129
, and GAS motifs 
75
 (Table 2.1), is intriguing. These 
patterns are known to stabilize TM helix association and also figure in the helix-helix 
packing of proteins that undergo large-scale conformational changes in response to 
lipidic environment, such as in mechanosensitive (MS) channels 
130
.  
 
Thus, we investigated whether FPs might adopt TM helical rather than surface 
orientations, and how this might relate to their mechanisms of action. If indeed FPs adopt 
a TM orientation, then one might envision a mechanism akin to SNARE proteins 
131-134
, 
in which both the target and vesicular proteins have TM helices that associate as 
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membrane fusion progresses. Accordingly, we investigate herein a class I fusogenic 
protein, F, from parainfluenza virus 5 (PIV5), which, like influenza virus HA and HIV 
gp41, has an N-terminal FP in the mature, cleaved protein 
87
. High-resolution structures 
are available for both the pre- and post-fusion forms of the ectodomain of the F protein 
135-137
, and the structure and function of its C-term-TM domain has been extensively 
investigated by scanning mutagenesis and Cys crosslinking 
138
. The sequence of the FP 
suggests that it also forms a TM helix 
56
. Moreover,  it has a single polar Gln residue, a 
residue known to promote helix-helix interactions in membranes 
61
, plus glycine and 
alanine residues in a heptad repeat pattern (Figure 2.1B), known to stabilize TM helix-
helix assembly 
59, 78, 139
 and pore formation 
129
.  The sequence variability of the FP across 
homologous viruses shows a heptad repeat in phase with the heptad repeat of the long 
water-soluble coiled-coil, which directly follows it (Figure 2.1C, 1D), interrupted only by 
a highly conserved region (residues 112-117) that is constrained by packing in the pre-
fusion trimer 
136, 140
. Consistent with this, the postfusion structure of PIV5 
135
 showed that 
the C-terminus of the fusion peptide is helical. Here, we show that this FP adopts a TM 
orientation in phospholipid membranes, specifically oligomerizing into a homohexameric 
bundle (6HB) and it also associates with the C-term-TM domain in micelles. 
Computational studies suggest that conformational changes involving zippering of the 
water-soluble coiled-coil in the ectodomain drive changes in helix-crossing angles that 
may lead to an initial heteromeric contact or “pin-prick” between the FP and the C-term-
TM leading to a fusion pore possibly lined by both protein and lipid. 
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Figure 2.1 Sequence conservation suggests a continuous helix including heptad repeat A 
(HRA) and the fusion peptide. (A) Postfusion crystal structure of the soluble domain of 
closely related hPIV3 virus F protein 
135
. Shown in magenta is HRA. Below HRA, in the 
postfusion membrane, is the predicted location of the fusion peptide. (B) Heptad repeat of 
the fusion peptide and HRA. The beginning of the crystallographic resolved region of 
HRA is shown in magenta. Heptad repeats of small residues in the fusion peptide are 
boxed. (C) Sequence entropy of the fusion peptide and HRA can be fit to a single 
sinusoidal function with period of 3.47 ± 0.02 residues/turn (r = 0.51). (D) Sequence 
entropy of the fusion peptide alone can be fit to a single sinusoidal function with a period 
of 3.51 ± 0.08 residues/turn (r = 0.59). 
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Table 2.1 Conservation of small residues (Ala, Gly) within four virus families.   
Each family uses a type I fusion protein with an N-terminal fusion peptide. Small 
residues are shown in bold.  Note that even distantly related viruses often conserve the 
position of small residues. 
 
Orthomyxoviridae: 
Influenza A H1  GLFGAIAGFIEGGWTGMIDGWYG 
Influenza A H3 GLFGAIAGFIENGWEGMIDGWYG 
Influenza A H5     GLFGAIAGFIEGGWQGMVDGWYG 
Influenza B        GFFGAIAGFLEGGWEGMIAGWHG 
Influenza C      IFGIDDLIIGVLFVAIVETGIGGYLLGS 
 
Retroviridae: 
HIV-1, Group M, Clade A     AIGMGAFFLGFLGAAGSTMGAASITLTVQA 
HIV-1, Group M, Clade B     AVGIGALFLGFLGAAGSTMGAASMTLTVQA  
HIV-1, Group M, Clade C     AVGIGAVFLGFLGAAGSTMGAASITLTVQV 
HIV-1, Group O              AVGLGMLFLGVLSAAGSTMGAAATTLAVQT 
HIV-1, Group N             AAFGLGALFLGFLGAAGSTMGAASITLTVQA 
HIV-2                       GVFVLGFLGFLATAGSAMGAASLTLSAQS 
SIV, rhesus monkey          GVFVLGFLGFLATAGSAMGAASLTLTAQS 
SIV, chimpanzee            AAFGLGALFLGFLGAAGSTMGAAAVTLTVQA 
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Human T-cell leukemia virus AVPVAVWLVSALAMGAGVAGGITGSMSLASG 
 
Paramyxoviridae: 
Human parainfluenza virus 1      FFGAVIGTIALGVATAAQITAGIALA 
Human parainfluenza virus 3      FFGGVIGTIALGVATSAQITAAVALV 
Simian parainfluenza virus 5     FAGVVIGLAALGVATAAQVTAAVALV 
Measles                          FAGVVLAGAALGVATAAQITAGIAL 
Sendai virus                     FFGAVIGTIALGVATSAQITAGIALA 
Nipah virus                      LAGVIMAGVAIGIATAAQITAGVALY 
Newcastle virus                  FIGAIIGSVALGVATAAQITAASALI 
Respiratory syncytial virus      FLGFLLGVGSAIASGVAVS 
 
Arenaviridae: 
Lassa fever                      GTFTWTLSDSEGKDTPGGYCLT 
Lymphocytic choriomeningitis     GTFTWTLSDSSGVENPGGYCLT 
Junin arenavirus                 AFFSWSLTDSSGKDTPGGYCL 
Machupo virus                    AFFSWSLTDSSGKDMPGGYCL 
Guanarito virus                  AFFSWSLSDPKGNDMPGGYCL 
Sabia virus                      GIFSWTITDAVGNDMPGGYCL 
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2.3 Results 
Association of Fusion and C-term-TM Peptides in Detergent Micelles 
Analytical ultracentrifugation (AUC) of the FP from PIV5 F protein in 
phospholipid micelles reveals cooperatively assembly into hexamers (Figure 2.2). The FP 
was dissolved in dodecylphosphocholine (DPC) micelles, and the density of the solution 
was adjusted to precisely match that of the DPC detergent 
82
 so that only the protein 
component contributes to the sedimentation equilibrium. Three samples prepared at 
differing peptide-to-detergent ratios were each centrifuged at four to five rotor speeds, 
respectively, for the wild-type and mutant Q120A. The data were then globally analyzed 
to extract the number of peptides per oligomer as well as the free energy of association 
82, 
139, 141
. The data conform very well to tightly associating and fully cooperative monomer-
hexamer equilibrium (Figure 2.3). The addition of lower-order intermediate states failed 
to improve the quality of the fit, indicating that the association was highly cooperative 
and specific for the formation of hexamers relative to other possible association states.  
 
The mutant Q120A also forms hexamers (Figure 2.2C, 2D, 3B), but its 
association is weaker than that of the wild-type peptide by 13.4 kcal/mol of hexamer, or 
2.2 kcal/mol of monomer. Glutamine (Gln) is well known to stabilize the association of 
TM helices 
61
 and the magnitude of the effect is similar. Thus, it is likely that the Gln 
helps stabilize TM helix association within the structure, although this residue is not 
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absolutely essential for forming the 6HB. Q120 is strongly conserved in related viruses 
(Table 2.1) and is a promising target for future studies using reverse-engineered viruses. 
 
While the C-term-TM domain has been shown to associate in the full-length 
protein 
138
, the C-term-TM peptide alone does not associate in DPC micelles (Figure 
2.4A). However, when unlabelled wild-type FP is introduced at a 1:1 ratio, the C-term-
TM-peptide strongly associates (Figure 2.4B), perhaps adopting a structure relevant for 
the postfusion state. Analysis of the sedimentation curves indicates that the TM peptide 
self-associates with the FP at least 20-fold less tightly than the corresponding heteromeric 
interaction with the C-term-TM peptide. 
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Figure 2.2 Analytical ultracentrifugation of fusion peptide wild-type (A, B) and mutant 
Q120A (C, D).  Single species fitting of wild-type (A) and mutant Q120A (C) PIV5 
fusion peptide suggests both associate as hexamers. The top of each panel shows the 
residuals of single species fitting. The species weight fraction is shown for wild-type (B) 
and mutant Q120A (D), indicating that hexamer is the dominant species composition for 
the wild-type, while oligomerization of the mutant Q120A requires significantly higher 
mole fractions. 
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Figure 2.3 Sedimentation equilibrium analysis of the wild-type (A) and mutant Q120A 
(B) fusion peptides in DPC micelles.  The absorbance was measured at 280 nm. The data 
was fitted as a monomer-hexamer equilibrium, resulting in a pKdissociation of 20.1 for the 
wild-type and a pKdissociation of 10.2 for the mutant Q120A.  The top of each panel shows 
the residuals of the fit. In this data analysis the concentration of peptide is the mole ratio 
of peptide/detergent and therefore is unitless.  
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Figure 2.4 Analytical ultracentrifugation of C-term-TM peptide alone (A) and C-term-
TM peptide-fusion peptide mixture (B).  No significant curvature has been observed in 
AUC data of TM peptide alone (A) suggesting that C-term-TM peptide does not self-
associate under these conditions. Single species fitting for a 1:1 mixture of C-term-TM 
peptide and fusion peptide (using the original sequence without a Trp label) suggests a 
strong interaction between these peptides. 
 
 
 
 
 
31 
 
Fusion Peptides Adopt a TM Orientation in Lipid Bilayers 
The secondary structure and orientation of the wild-type and mutant FP in 
micelles and deuterium oxide (D2O) hydrated bilayers were evaluated using circular 
dichroism (CD) and attenuated total reflection IR spectroscopy (ATR-IR), respectively. 
The CD spectra of both peptides in DPC micelles are typical of alpha-helix (Figure 2.5) 
indicating that the association observed by AUC corresponded to the formation of helical 
bundles. The IR spectra in the amide I region of the FPs shows a single, sharp peak at 
1656 cm
-1
, indicative of a dehydrated helical conformation 
142
 in bilayers (Figure 2.6 A, 
B). The dichroic ratio for parallel versus perpendicularly polarized light was 3.2 and 3.6 
for the wild-type and mutant, respectively. These values correspond to an orientation of 
approximately 29º and 22ºrelative to the membrane normal 
143, 144
, assuming the entire 
peptide is fully helical and the bilayers are well ordered. Deviation from helical geometry 
or disorder of the bilayer would result in somewhat lower dichroic ratios. In this case, the 
true angles would be even closer to parallel to the bilayer normal. Thus, both peptides 
have a strong preference to adopt a TM orientation relative to other possibilities in which 
the helix was either randomly oriented or oriented parallel to the membrane surface. 
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Figure 2.5 CD spectra of fusion peptide wild-type (A) and mutant Q120A (B). The 
spectra show that both wild-type and Q120A are predominantly α-helical at a 
peptide:DPC ratio of 1/200.  
 
 
 
 
 
 
 
 
 
33 
 
 
Figure 2.6 Attenuated total reflection IR spectroscopy (ATR-IR) of fusion peptide wild-
type (A) and mutant Q120A (B) in phopholipid (POPC) bilayers. The sharp peak at 1656 
cm
-1 
is indicative of alpha helical secondary structure. The TM orientation is 
demonstrated by the much greater intensity of the 1656 cm
-1 
amide I bond for parallel (0º) 
versus perpendicular (90º) polarized incident light (relative to the membrane normal). 
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Computational Modeling of the 6HB 
To model the FP 6HB, the possible structural space was systematically sampled 
and scored using a protocol akin to the conformational search of Brunger, Arkin and 
coworkers 
145
. The strong heptad repeat (Figure 2.1C, D) is indicative of a left-handed 
helical bundle. A left-handed bundle also would be consistent with a continuous helical 
structure beginning in the soluble heptad repeat A (HRA) and continuing directly to 
fusion peptide, as the conservation pattern suggests (Figure 2.1C). Moreover, the nature 
of viral fusion, with asymmetric insertion of peptides into the target membrane, suggests 
that the FPs comprising the 6HB should adopt a parallel orientation. Symmetric, parallel 
coiled-coils can be described by a limited number of variables 
146. Three of these: α-
helical phase (φ), pitch angle (α), and superhelical radius (R) were allowed to vary and 
were sampled systematically in search of optimal coiled-coil structures.  For each 
structure, optimal rotamers were selected and the structure then minimized.  Each 
structure was scored using the CHARMM energy function in an implicit membrane 
environment 
147, 148
 to select candidate models. 
 
The energy of a particular 6HB conformation depends primarily on the phase, φ. 
Multiple energy minima are observed as the helices are rotated (Figure 2.7A).  Five left-
handed structures were selected, corresponding to the lowest energy basins, for further 
refinement using molecular dynamics (MD) simulations in an explicit fully hydrated lipid 
bilayer. The lowest predicted energy for an antiparallel orientation 6HB was selected as a 
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negative control.  It was less stable in MD simulations than the low-energy parallel 
models and was not further pursued (Figure 2.7, 2.8). 
 
MD simulations on the five parallel 6HB structures (labeled according to their 
phases, φ = 40º, 43º, 88º, 196º, and 300º, respectively) show that the orientation of the 
Gln side chain is crucial for 6HB stability. Two closely related structures, φ = 40º and 43º 
(Cα RMSD = 1.6 Å), place the Gln in a d position within the coiled-coil while the phase 
88º structure places the Gln in a position.  The remaining two structures have Gln facing 
the lipid (phase 196º and 300º), are much less stable than the interior-facing ones (Figure 
2.7B, 8), and rapidly depart from their initial structures (as measured by Cα RMSD), 
while structures with an interior Gln are stable near the initial structure for 50 ns of MD 
simulation. 
 
Of the interior facing Gln structures, the phase 40º and 43º models are most stable 
during the MD simulation and best maintain a symmetric coiled-coil structure (Figure 
2.8). These models form a highly stable hydrogen bond network in the interior of the 
6HB coiled-coil (Figure 2.9A), consistent with the important role Gln plays in 
oligomerization (Figure 2.2). The periodically conserved small residues of the FP are 
found at the helix interface in this model. Of note is the penetration of water into the core 
of the 6HB from the viral side of the membrane (Figure 2.9B). It is possible that the 
formation of the FP 6HB structure may reduce the barrier to fusion by initiating 
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formation of a nucleus for expansion into the later, much larger fusion pore. In the less 
stable models (phases 88º, 196º, and 300º) the water distribution is not stable due to 
either a less favorable arrangement of the Gln side chains (88º) or to their location outside 
the pore (196º and 300º) (Figure 2.10). 
 
The most stable 6HB (φ=40°) structure was then used to compute an FTIR 
dichroism ratio following the method of Arkin and coworkers 
149, 150
 where the individual 
residue dipoles are combined. The computed dichroism ratio is 2.95 ± 0.07 (mean and 
standard deviation over the MD simulation), in good agreement with the experimental 
value (Figure 2.6). 
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Figure 2.7 Computational prediction of the hexameric helical bundle.  (A) Heat map 
shows predicted energies of coiled-coil models with different radii and phases.  Regions 
in black are predicted to be more energetically favorable.  (B) Backbone atom RMSD of 
five coiled-coil models selected from (A) and one antiparallel model generated using an 
analogous procedure.  Parallel models are labeled according to their phase angle. 
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Figure 2.8 Final structures of the MD simulations of different hexamer models and coiled 
coil parameters as a function of time.  (A-F) Final backbone structures in cartoon 
representations of five parallel models of the hexamers corresponding to the phase angles, 
φ, of 40º (A), 43º (B), 88º (C), 192º (D), 300º (E), and of the antiparallel model (F). The 
heavy atoms of the Gln120 side chains are drawn in blue.  (G-L) Coiled coil parameters 
as a function of time of the six models, in the same order as in (A-F); the deviations from 
the initial values of the pitch angle α and of the phase angle φ (Δα and Δφ) are plotted in 
green and red, respectively; the deviation of the radius (Δr) is plotted in blue. 
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Figure 2.9 Computational model of the PIV5 F fusion peptide hexameric bundle. (A) The 
Q120 residues form hydrogen bonds with one another as well as waters on the interior. 
(B) Side view shows the bundle oriented with the N-terminal end (which presumably 
faces the cellular interior) up. Water is shown in blue. Not shown for clarity are the 
phospholipids as well as one helix closest to the viewer. 
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Figure 2.10 Density of oxygen atoms from water molecules through the pore of the 
hexamer bundle.  From left to right, data from the following models are plotted: φ = 40º, 
43º, 88º, 192º, 300º, and the antiparallel model. The density is expressed in number of 
atoms per Å, and plotted as a red line along the horizontal axis.  For comparison, the 
density profile from the φ = 40º model is also shown as a dashed blue line in the other 
models (duplicated for the antiparallel model, which is symmetric with respect to the 
membrane plane).  For those models featuring pore-lining Gln120 side chains, the region 
occupied by their nitrogen and oxygen atoms is highlighted in green. 
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2.4 Conclusion and Discussion 
Comparison of the properties of the FP from PIV5 with other systems:  
Here we provide experimental evidence that the FP from the PIV5 F protein is 
able to adopt a TM helical conformation when incorporated into lipid bilayers, and that it 
associates with the C-term-TM helix. Similarly, a FRET assay 
151
 suggested the C-term-
TM domain of influenza HA interacts with its FP, although the orientation of the peptide 
in the complex was not determined. These findings extend the structural and mechanistic 
similarity between the PIV5 fusogenic F protein and SNARE proteins to include not only 
their water-soluble coiled-coil domains, but also their membrane-interactive domains. 
Recent biochemical and structural studies on SNARE proteins 
131
 suggest a zippering 
motion of the water-soluble coiled-coils that continues into the TM domains promoting a 
heteromeric interaction between the two TM helices to provide part of the driving force 
for bilayer fusion. 
 
The conformation and TM orientation of the FP from the PIV5 F protein is clearly 
defined by IR dichroism (Figure 2.6), which showed an average helical tilt of 20° to 30° 
relative to the membrane normal, and also ruled out the possibility of significant amounts 
of β-structure. The situation is less clear for other FPs, which often are found to adopt 
more “oblique-oriented” or “tilted helical conformation” 152, in which the helix is 
oriented at 30 to 70° relative to the bilayer normal, either spanning the bilayer or 
penetrating a single leaflet, depending on the length of the synthetic peptide investigated 
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96-98, 109, 116-118
. For example, the N-terminal peptide of gp41 has been reported to adopt a 
TM 
99
, tilted 
112-114
, and beta 
103, 110-112, 115
 conformation in various membrane mimetics. 
Synthetic versions of the FP from influenza virus HA2 span approximately half of the 
bilayer width, but as a bent helix 
96
 or helical hairpin 
102
 in micelles. However, the 
hydrophobic region of the FP in the intact virus spans residues up to Arg25, while NMR 
studies have been conducted with peptides spanning between 20 to 23 residues, with an 
artificial oligo-Lys tail added to enhance water-solubility. The dynamics and 
conformational properties of the 20- versus 23-residue peptide differ significantly 
102
, as 
expected for a finely tuned system with multiple low-lying energy wells that are 
progressively populated during fusion. These distinct structural states, and their 
sensitivity to small changes in sequence and environment, may be both functionally 
relevant and reflect the energetic fine-tuning of the landscape and the dynamic nature of 
fusion.  
 
Within a family, the FPs of viral fusion proteins have highly conserved sequence 
motifs, such as heptad repeats of small residues, that are similar to those important for 
association of other oligomeric TM helical bundles 
75, 128, 129
 (Table 2.1), suggesting that 
TM helix-helix association might be relevant to fusion. In this regard, it is interesting to 
compare the avidity of homo- and hetero-oligomer formation for the C-term-TM and FP 
of the PIV5 F protein. Isolated FPs homo-oligomerize strongly and specifically to a 6HB. 
The C-term-TM peptide also engages in helix-helix interactions, which have been 
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experimentally demonstrated using disulfide crosslinking of the full-length protein
138
. 
However, the present study shows that the C-term-TM helix homo-oligomerizes more 
weakly than the FP in the absence of the trimeric ectodomain, but associates tightly with 
the FP (Figure 2.4). The hierarchy of association strengths mimics the assembly process 
of the ectodomains, in which the weakly associated parallel C-terminal coiled-coil trimer 
(contiguous with the C-term-TM helix) dissociates and zippers up along the N-terminal 
coiled-coil (contiguous with the FP) to form the final antiparallel bundle
85-88
. The C-term-
TM and FP may likewise zipper as an antiparallel bundle in forming the postfusion state. 
 
A provisional model for membrane fusion by class I proteins: lipid-centric and “pin-
prick” mechanisms.  
In the absence of fusion proteins, the process of bilayer fusion is a physical 
process with multiple high-energy intermediates 
153, 154
 corresponding to: 1) diffusion of 
the membranes together; 2) dehydration of the bilayers as the headgroups of opposing 
bilayers come into still closer proximity; 3) formation of a lipidic stalk, 4) hemifusion, 5) 
pore formation and expansion. Viral fusion proteins and SNARE proteins utilize 
essentially irreversible, energetically favorable conformational transitions to lower the 
activation energy for membrane fusion 
131, 132, 153, 154
. Thus, they are active participants 
that shape the energy landscape. There are multiple classes of fusogenic proteins, and 
there is significant variation in the number of fusion proteins per particle, suggesting 
additional biological requirements, presence of accessory proteins, or lipid compositions 
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86
. Here we consider how the class I fusogenic proteins might orchestrate energetic 
landscape-shaping mechanisms. The present observations provide molecular detail to two 
limiting hypothetical models, representing extremes in a continuum of kinetic pathways 
that depend on the protein and experimental variables.  
 
In a “lipid-centric” model of viral fusion, the proteins hold the bilayers in close 
proximity to promote the progression through lipidic intermediates of fusion (Figure 
2.11A). The FP and C-term-TM domains are hypothesized to remain outside of the point 
of membrane apposition, which is instead made up exclusively of lipids. The ability of 
the FP to embed deeply into the membrane and engage in favorable C-term-TM to FP 
interactions provides a mechanism for forcing the two bilayers into close proximity 
within a very small area, as the coiled-coil domains of pre-associated proteins zipper 
through the water-soluble regions and extend into the membrane. Favorable FP to C-
term-TM interaction provides a continuously downhill process for the protein component, 
facilitating bilayer-bilayer apposition. Moreover, for systems in which many fusion 
proteins are required for fusion, the association of the FP in target membranes might 
bring sufficient fusion proteins near the protein-free zone.  
 
A second model of fusion envisions that fusion proceeds via an initial contact 
between the TM domains in the two bilayers.. The central point of protein contact can be 
thought of as a “pin-prick” that expands into a fusion pore. This model is in contrast to 
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those that propose a gap junction-like pore 
107
 as only the initial contact is mediated 
solely by protein domains. The 6HB is hypothesized to be at the center of the contact 
region between the two membranes. Subsequent pore formation involves the initial 
protein contact expanding with recruitment of additional lipids with their headgroups 
facing the growing fusion pore (note the incursion of phospholipids in Figure 2.11B).  
 
To probe the hypothesized mechanism further, we built models of two bilayers in 
the process of fusion, and asked how the previously defined structural intermediates of 
the water-soluble and membrane domains of the protein might map onto likely lipid 
intermediates, lowering the activation energy of the process. Figure 2.11 shows how a 
hexamer of the PIV5 FPs might serve as a pin-prick to nucleate a pore at three critical 
points: the extended prehairpin intermediate (left), membrane apposition (center), and 
postfusion (right). As the conformational change progresses the TM bundles formed by 
the C-term-TM and FP helices first dock, then coalesce into heteromeric bundles. The 
initial zone of inter-membrane contact involves favorable protein-protein interactions 
rather than energetically unfavorable dehydration of the bilayer headgroups, and the 
fusion of these two helical bundles provides a low-energy pathway to direct fusion of the 
bilayers, which remain associated with the TM bundles throughout the process.  
 
The latter mechanism provides a rationale for the multiple conformational forms 
and strong intra-family conservation in the FP sequences, which must associate with 
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graded affinities in a homomeric as well as heteromeric fashion. It also explains how the 
addition of various shaped lipids can either promote or inhibit fusion. As the protein 
conformational change proceeds, the C-term-TM and FP become more tilted (relative to 
the normal of the initial bilayer). The driving force for tilting includes the zippering of the 
coiled-coil and favorable heteromeric TM interactions. The recent structure by Rees and 
coworkers of the MscL MS channel 
130
 illustrates how mechanical forces from external 
domains and lipid-specific effects result in changes in helical tilt and channel radius. 
Changes in the membrane lateral surface pressure profile cause helices comprising the 
MscL channel to slide relative to each other, increasing their tilt and opening the channel 
like a diaphragm. In a similar manner, mechanical forces from conformational changes as 
well as lateral surface pressure effects associated with the lipid composition would couple 
to the energetics of protein-mediated bilayer fusion.  
 
The highly conserved small glycine and alanine residues, which are found in both 
MS channels and class I viral FP (Figure 2.1, Table 2.1), are ideally suited for helix 
sliding because they present relatively smooth interfaces 
74, 128
. The channel formed by 
MscL also expands with these conformational changes, both opening the channel and 
increasing the surface area available for protein-protein interaction. The hypothetical 
tilting of the FP and C-term-TM domains would increase the number of residues in 
contact with the hydrophobic region of the bilayer beyond the length of 20 residues 
typically seen for TM helices. This longer membrane-suitable region is observed for the 
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PIV5 C-term-TM and contributes to fusion 
138
. It is also observed in other viruses such as 
influenza 
132
 and HIV, where shortening the length of C-term-TM helices can halt the 
fusion process 
155, 156
. 
 
Figure 2.11A compares the lipid-only and pin-prick mechanisms; in both cases 
protein-protein interactions between membrane-embedded helices bring the two bilayers 
into intimate contact. After the bilayers are brought close together, different proteins 
might take different pathways to achieve fusion. The zone of adhesion can widen to 
create a hemifusion intermediate, particularly for situations in which one of the two 
helices does not fully span the bilayer (Figure 2.11A). Alternatively, the protein might act 
as a pin-prick to nucleate the fusion pore (Figure 2.11B). The requirements for tight and 
specific interactions between the membrane-embedded helices will also vary depending 
on the specifics of the mechanism. 
 
Overall, it seems likely that a continuum of mechanisms is needed, with protein-
rich and lipid-rich patches in the fusion pore for many proteins. This in turn will allow for 
failures leading to lipid mixing-arrested hemifusion when the fusogenic peptides are 
mutated. The present work favors a protein-centric but not a protein-only fusion 
mechanism. The pin-prick mechanism should face a less difficult pathway for inter-
bilayer interaction to initiate the pore. In addition, it bridges SNARE-like and virus-like 
mechanisms while explaining why different angles of insertion have been observed for 
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various fusion peptides. Thus, this mechanism provides a general framework for 
understanding protein-mediated membrane fusion.  
 
 
Figure 2.11 Provisional model of PIV5 fusion. (A) Schematic diagrams of the limiting 
extremes of lipid-centric and pin-prick fusion. (B) Shown is a model of the 
conformational change of the F protein (FP) hexamer (6HB) from a pre-hairpin, extended 
intermediate (left) to a point of membrane apposition (middle) and finally to the 
postfusion state (right). Proposed conformations of the FP 6HB are shown in the insets 
along with 90º rotations. Note the increased tilt of the FP moving from the extended 
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intermediate to the point of membrane apposition as well as the recruitment of lipid 
headgroups to the nascent pore. FPs are shown in red and blue, C-term-TMs are shown in 
magenta and yellow. The C-term-TM in the middle image contains two trimeric 
structures 
138
. 
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2.5 Method 
Peptide Synthesis, cleavage and purification 
The wild-type sequence for PIV5 fusion peptide (FP) is  
FAGVVIGLAALGVATAAQVTAAVALVKANE. The only glutamine, residue 120 
(using the numbering of the fusion protein before cleavage), was mutated into alanine for 
the mutant Q120A. One tryptophan was added to the C-terminus of both the wild-type FP 
and the mutant Q120A using a flexible (Gly)3 linker in order to provide absorbance at 
280 nm for concentration measurements.  The sequence for C-terminal membrane 
segment TM (C-term-TM) peptide is VLSIIAIALGSLGLILIILLSVVVWK, and contains 
a tryptophan for concentration measurements. 
 
Peptide synthesis, cleavage and purification were conducted as previously 
described 
139
. 0.1 mmole scale synthesis was manually conducted on RINK amide resin 
(Novabiochem) by N-9-fluorenylmethyloxycaronyl (Fmoc) amino acids (using a four-
fold molar excess) in a microwave synthesizer (CEM Discover).  The peptide was 
cleaved using a trifluoroacetic acid (TFA):water:1,2-ethanedithiol ratio of 95:2.5:2.5. 
Peptide purification was run on a semi reverse phase HPLC (Vydac, C4 column, 250mm 
x 10mm i.d.) at 60º C in a gradient between solvent A (water with 0.1% TFA) and 
solvent B‟ (isopropanol: acetonitrile:water in a ratio of 6:3:1 with 0.1% TFA). The 
identity and purity of the peptide were confirmed by MALDI-TOF mass spectrometry 
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(Voyager model DE RP; PerSeptive Biosystems) and analytical reverse phase HPLC 
(Vydac C4 column). 
 
Sedimentation equilibrium of analytical ultracentrifugation (AUC) 
Sedimentation equilibrium experiments and data analysis were performed as 
described previously 
82, 139, 141
. Wild-type and mutant Q120A FPs was mixed with 
dodecylphosphocholine (DPC) in 2,2,2-trifluoroethanol (TFE). The cocktail was dried in 
a glass vial, lypholized over night, and rehydrated with buffer in order to reach the DPC 
concentration of 8mM.  This pH-7.3 buffer contained 100 mM HEPES, 100 mM NaCl 
and 37% D20 in order to match the density of the detergent.  
 
Three groups of samples were prepared as peptide:DPC molar ratios of 1:50, 
1:100 and 1:200.  The experiments were conducted at 25ºC using a Beckman XL-I 
analytical ultracentrifuge at 30, 35, 40, and 45 kRPM.  In addition, some samples used 
additional experiments at 48 kRPM.  Data obtained were globally fitted to a nonlinear 
least-squares curve by IGOR Pro (Wavemetrics) as previously described 
157
. 
 
Two AUC experiments were carried out to identify the interaction between the FP 
and the C-term-TM peptide. First, the C-term-TM peptide alone was prepared as a 
peptide:DPC molar ratio of 1:100. No significant curvature has been observed in AUC 
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data despite running the sample at multiple speeds (30, 35, 40, 45 and 50 kRPM). The C-
Term-TM peptide and the FP were mixed in a 1:1 molar ratio at a total peptide:DPC 
molar ratio of 1:50 (Figure 2.4B left side) and 1:100 (Figure 2.4B right side). The 
experiments were conducted under the same conditions as those for the FP alone. The FP 
used here was synthesized using the original sequence, without Trp labeled, thus the FP 
itself did not have absorbance at 280nm. The significant curvature from the mixture 
suggests the strong interaction between C-term-TM peptide and FP. The concentration of 
the C-term-TM peptide was identified based on the absorbance at 280nm. The 
concentration of the FP was identified using a micro-balance and dissolved in TFE. Thus 
the determined concentration for the FP here might have 5% error from absorbing water 
from atmosphere, and presumably contributed the fitting error in the left side of the 
curves. 
 
To estimate a lower limit of the strength of C-term-TM association with FP, the 
avidity of C-term-TM homooligomerization with and without FP were compared. For C-
term-TM alone, the association is weak. The midpoint occurs in the range of 1:3-1:5 
peptide:detergent. The midpoint is similar when fit as a dimer, trimer, or hexamer. In the 
presence of FP, the midpoint of heteromeric association occurs at approximately 1:100 
peptide:detergent. Because the heteromeric interaction appears to involve an equal 
number of FP and C-term-TM peptides, for this calculation the molecular weight, 
extinction coefficient, and partial specific volume values for the FP and C-term-TM were 
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averaged and fit to a monomer-12mer equilibrium. The ratio of these self-association 
values provides a conservative estimate of C-term-TM association of at least 20 times 
stronger association in the presence of FP than in isolation. 
 
Circular Dichroism (CD) 
CD spectra were collected with a Jasco J-810 spectropolarimeter and a 0.1 cm 
quartz cell using a 1nm step at 25ºC. Peptide at 12.5 μM was incorporated into 2.5 mM 
detergent DPC using the method described above and rehydrated into aqueous buffer 
containing 10 mM disodium phosphate of pH 7.4. The CD spectrum of each peptide was 
obtained by subtracting the spectrum of DPC alone and averaging over three scans. 
 
Attenuated total reflection IR spectroscopy (ATR-IR) 
ATR-IR experiment and data analysis were conducted as previously described 
143, 
144. 140 μL of 300 μM wild-type or Q120A mutant FP was mixed with 25.5 μL of 32.9 
mM 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), in order to make a 
peptide:POPC ratio 1:20. The cocktail was loaded on the surface of ATR Ge crystal 
evenly and dried by air.  The film was rehydrated by D2O-saturated air overnight in 
closed environment of D2O bath.  All infrared spectra were measured in a Nicolet 
Magna-IR 860 spectrometer using 1 cm
-1
 resolution. During data acquisition high-purity 
N2 gas continuously purged the spectrometer and D2O hydrated high-purity N2 gas was 
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continuously purged upon the sample film to eliminate the spectral effects of water in air.  
The polarized mirror was adjusted to 0º and 90º in order to create incident light oriented 
parallel and perpendicular to the lipid normal, respectively.  Each spectrum of a peptide 
was subtracted by the spectrum of the crystal alone at 0º and 90º, respectively. A total of 
64 scans were averaged and Fourier-transformed to both wild-type and mutant. The 
dichroic ratio of 1656 cm
-1 
amide I bond absorption is computed for parallel (0º) versus 
perpendicular (90º) polarized incident light relative to the membrane normal. The 
dichroic ratio was then applied to equations in 
143
, in order to calculate the peptide 
orientation relative to the membrane normal.  
 
Sequence conservation 
Because buried positions are more conserved than solvent or lipid exposed 
positions, an α-helix will, in general, show a sinusoidal conservation pattern with 
approximately 3.6 residue periodicity 
158
.  If the helix is bent as part of a coiled coil, 
seven residues occur over every two turns of the helix, giving an average of 3.5 residue 
periodicity.  A beta sheet, however, would be expected to show approximately 2 residues 
per period, as the residues alternate sides of the strand. 
 
To determine the sequence conservation of the FP, sequences from the NCBI non-
redundant database (February 9, 2009) were selected if the sequence matched the PIV5 f-
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peptide sequence (FAGVVIGLAALGVATAAQVTAAVAL) to an E-value of 1 or less 
159
.  The program Cd-hit 
160
 was used to remove sequences with higher than 90% 
sequence identity.  The sequence entropy of each sequence position is calculated as: 
Entropy = -Σ i = 1,20  { fi ln fi }, where fi is the fraction of residue i. The entropy, x, was fit 
to a sine wave according to the formula: y = a*sin[2π(x+b)/c] + d, where the periodicity is 
found in variable c. 
 
Creation of coiled coil models 
All-atom protein backbones of the TM coiled-coil FP hexameric bundle (6HB) 
were created using the Crick parameterization 
146
 according to a previously published 
method 
161
. Three parameters were allowed to vary: alpha helical phase (φ), pitch angle 
(α), and superhelical radius (R).  The other coiled coil parameters were held fixed.  φ was 
varied from 0º to 359º in 1 deg steps;  α from 5º to 20º in 1 deg steps; and  R from 9.0 to 
11.0 Å in 0.1 Å steps. These ranges were chosen based on the values observed in other 
coiled coils and such that no backbone clashes would occur in the complex. 
 
For each backbone 6HB model, side chains were placed using the program scap 
162
 and hydrogens placed by reduce 
163
.  Each structure was subject to a constrained 
minimization in CHARMM22 
147
 of 50 steps to decrease, but not remove, the penalty for 
a clash in a given structure and to not move significantly from the initial coiled coil 
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parameters.  The energy of the structure was then calculated using CHARMM22 and 
IMM1 implicit solvation 
148
 with a non-bonding interaction cutoff of 9.0 Å.  The selected 
minimized models had the following (φ, α, R) parameters before simulation: (40º, 10.3 Å, 
22.1º), (43º, 10.4 Å, 15.9º), (88º, 10.4 Å, 16.0º), (196º, 9.7 Å, 13.6º), and (300º, 10.7 Å, 
15.6º).    The parameters of the antiparallel model were: (24º, 10.2 Å, 9.0º) with a z-offset 
of 0.5 Å. 
 
Molecular dynamics simulations 
Models of the FP hexameric bundle (6HB) were embedded in a lipid bilayer 
composed of 140 POPC molecules (80x80 Å in size), capped on each side by a water 
layer of 18 Å thickness (6,500 water molecules in total).  Periodic boundary conditions 
were applied.  11 Na
+
 and 11 Cl
-
 ions were distributed in the water region, corresponding 
to a salt concentration of about 150 mM.  The six peptides and the ions were described by 
the CHARMM27 force field 
164
, the water molecules by the TIP3P force field 
165
, and the 
lipid molecules by the united-atom force field recently developed by Hénin et al, which 
provides nearly identical physicochemical properties to the CHARMM27 lipid 
166
.  The 
van der Waals interactions were truncated at 12 Å, and a grid resolution of 0.75 Å was 
used to treat the electrostatic interactions with the Particle-Mesh-Ewald (PME) scheme 
167
. 
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Each 6HB system was simulated by molecular dynamics (MD), using a time step 
of 2 fs. A Langevin thermostat 
168
 was applied to maintain a temperature at 310 K (~37 
C), and a Langevin-piston barostat 
169
 to keep a pressure of 1 bar along the bilayer normal.  
In the two directions parallel to the membrane, instead, a constant surface tension of 20 
dyn/cm
2
 was enforced.  The NAMD program 
170
 was used to perform all the MD 
calculations presented here. 
 
Because the interactions between the peptides and the surrounding lipids are of 
major importance to this study, and due to the fact that the starting HB structures were 
modeled within an implicit membrane, a rather long equilibration phase was performed.  
For each starting structure, a restraint of 10 kcal/mol/Å was applied to the peptide heavy 
atoms for the first 2 ns, and on the backbone heavy atoms only for the following 7 ns. 
The time evolution of the system was monitored during the following 50 ns of MD 
simulation without restraints. 
 
The density of water oxygen atoms in Figure 2.8 was computed by counting all 
atoms within a radius of 12 Å from the central axis of the bundle.  We used this criterion 
to account for the wide aperture of certain 6HB models (φ = 88º, 300º) and the 
oscillations of the bundle with respect to the membrane normal, while not including at the 
same time a detectable number of water molecules in the lipid interstitial regions: water 
density profiles computed with different radii do not differ significantly between z = -15 
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Å and 15 Å.  The water density isosurface in Figure 2.9B shows instead the distribution 
of all water molecules of the system in the HB (φ = 40º) simulation. 
 
FTIR Dichroism calculations 
Following the method of Arkin and coworkers
150
, we calculated the expected 
dichroism ratio by summing the contributions to carbonyl groups to each polarization 
given the backbone dipoles vectors in the molecular dynamics trajectory.  For these 
calculations 5% disorder was assumed.  Because non-helical termini and the first three 
helical residues are expected to exchange with D2O, only residues 108 through 126 were 
used for the calculation.  Including the full FP gives very similar results. 
 
Modeling of the fusion process 
To model the fusion process, both the PIV5 F protein and the membrane needed 
to be modeled. A 200 Å by 200 Å POPC lipid bilayer was created using VMD 
171
.  For 
early stages of the fusion model, the bilayer was perturbed using a cosine function with 
an increasing amplitude centered at the region that would become the point of membrane 
apposition.  Later stages incorporated increasing fractions of the conformation of a 
catenoid that makes up the final, postfusion conformation of the model.  The diameter of 
this pore is estimated to be 20 Å based on experimental results for influenza 
hemagglutinin 
105, 172
.  For the catenoid, the midpoint of the membrane followed the 
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mathematical formula while lipids were rotated to be perpendicular to the surface. Lipid 
density was maintained between the initial flat membrane surface and the catenoid 
structure. 
 
To model the F protein, first the available prefusion and postfusion crystal 
structures were combined to create a model of the prehairpin intermediate that bridges the 
viral and target cell membranes. Transmembrane domains were modeled either as coiled 
coils extended into the membrane or using the existing model of the prefusion TM 
138
.  
Loops were modeled using loopy 
173
, the side chains were repacked using Rosetta 
174
, and 
the structure minimized using the CHARMM22 energy function 
147
.  The structure of the 
postfusion state comes from the closely related hPIV3; the sequence of PIV5 was 
threaded onto the structure using Rosetta and minimized using the CHARMM energy 
function. 
 
For fusion intermediates, the membrane associated domains were first modeled.  
The hexameric model of the fusion protein was taken as the initial state for the prehairpin 
intermediate.  The helices were then tilted in 10º increments and slowly moved outward 
from the center to mimic the conformational change proposed for the MscL channel 
130
. 
In parallel, two TM domain trimers 
138
 were initially at a distance due to the conformation 
of the prehairpin intermediate, then brought close together and tilted relative to each other 
as may occur under the tension caused by zippering of the soluble coiled coil domains. 
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The soluble portions of the F protein trimers were tilted to connect to the FPs at 
each step. Loops between the FP and HRA were connected using loopy 
173
 and Pymol 
sculpting. The conformation of the exterior coiled coil, HRB, was then modified to 
connect to the TM domain using an loopy in-house loop modeling program and the BBQ 
backbone modeling program 
175
. 
 
 
2.6 Contributions 
Yao Zhang performed all the experiments and related analysis in this chapter, 
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performed the computational modeling and molecular dynamic simulations.  
This chapter has been published in Proceedings of the National Academy of 
Sciences, 2011:108(10):3958-63. 
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3 Chapter 3: Experimental and computational evaluation of 
forces directing the association of transmembrane helices 
 
3.1 Abstract 
The forces that define the interactions of transmembrane helices have been 
evaluated using a model membrane-soluble peptide (MS1), whose packing is modeled on 
the two-stranded coiled-coil from GCN4. The thermodynamic stability of water-soluble 
coiled-coils depends on the side chain at the buried a position of the repeat, favoring 
large hydrophobic residues over small side chains. Here we show that just the opposite is 
true for the membrane-soluble peptide. Analytical ultracentrifugation and equilibrium 
disulfide interchange show that the stability of MS1 is greatest when Gly is at each a 
position of the heptad repeat (MS1-Gly), followed by Ala > Val > Ile. Moreover, MS1-
Gly has a strong tendency to form antiparallel dimers, MS1-Ala forms a mixture of 
parallel and antiparallel dimers, while MS1-Val and MS1-Ile have a preference to form 
parallel dimers. Calculations based on exhaustive conformational searching and rotamer 
optimization were in excellent agreement with experiments, in terms of the overall 
stability of the structures and the preference for parallel vs antiparallel packing. The 
MS1-Gly helices are able to achieve more favorable and uniform packing in an 
antiparallel dimer, while MS1-Val and MS1-Ile have more favorable van der Waals 
interactions in a parallel dimer. Finally, the electrostatic component arising from the 
partial charges of the backbones become significant in the antiparallel MS1-Gly and 
MS1-Ala conformations, due to close packing of the helices. Thus, van der Waals 
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interactions and electrostatic interactions contribute to the stability and orientational 
preferences of the dimers. 
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3.2 Introduction 
While our understanding of the features stabilizing the structures of water-soluble 
proteins has reached an advanced state, a parallel understanding of membrane protein 
folding is only beginning to emerge.
59
  Previous work on water-soluble proteins suggests 
that the burial of hydrophobic residues plays a crucial role for folding.
176, 177
 Similarly, 
the replacement of large apolar sidechains with smaller residues in the interior of 
membrane proteins results in introduction of cavities with a concomitant loss in 
thermodynamic stability.
178
 From this perspective, the packing of large apolar sidechains 
can stabilize the folded structure of membrane protein. By contrast, statistical,
74, 75, 179-181
 
computational
77, 182, 183
 and experimental
77, 182, 184
 studies have demonstrated that small 
side chains, such as Ser, Ala and Gly, occur frequently at the helix-helix interface of 
membrane proteins, suggesting that the appropriate packing of these residues might 
provide an even stronger driving force for transmembrane (TM) helix association. We 
therefore compared the effects of packing large vs. small apolar sidechains, using a 
simple transmembrane TM helical dimer.  
 
Coiled-coils, such as the leucine zipper from GCN4,
176, 177
 have a repetitive 7-
residue repeat providing a conceptually simple system for studying sidechain packing. By 
convention, the residues at the a and d positions of the heptad pack in the core of a coiled 
coil.  The stability of water-soluble coiled-coils scales with the size and hydrophobicity 
of the sidechains at the a position increasing over the series Gly < Ala <Val < Ile.
177, 185
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Interestingly here we show just the opposite rank for MS1, a membrane-soluble version 
of a leucine zipper. 
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3.3 Results and Discussions 
MS1 is a membrane-soluble derivative of GCN4-P1, rendered lipophilic by 
converting its exposed polar sidechains to apolar residues, while maintaining the core 
residues constant.
60
 We synthesized a series of MS1 variants in which each of the four a 
positions was varied to Gly, Ala, Val and Ile (Figure 3.1). Each of these peptides is 
predominantly helical in dodecylphosphocholine (DPC) micelle as determined by circular 
dichroism over the entire range of peptide/DPC ratios studied here (Figure 3.2). Their 
assembly was first examined in DPC micelles by analytical ultracentrifugation (AUC) 
under conditions where the density of the solution is adjusted by addition of D2O to 
eliminate the mass contribution of DPC. The degree of association of membrane peptides 
in micelles depends on the concentration of peptide in the micelle phase as reflected in 
the peptide/detergent ratio. Over all experimentally accessible peptide/detergent ratios, 
MS1–Gly was fully dimeric, MS1-Ala adopted a monomer-dimer equilibrium, and the 
most hydrophobic peptides, MS1-Val and MS1-Ile, were predominantly monomeric 
(Table 3.1, Figure 3.3). This ranking is precisely the opposite of that found in water-
soluble structures. 
 
To explore the association strength of the MS1 variants we employed the method 
of equilibrium thiol/disulfide exchange,
141
 which is well-suited for examining weak 
interactions. The N-terminus was modified with a flexible three-glycine linker followed 
by a cysteine (Figure 3.1C). After peptides were incorporated into detergent micelles, 
redox buffer was added to bring the system to the following equilibrium (scheme 1). 
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Scheme 1.   
2MonSH DimSH DimSS
GSSG 2GSH
Kdim
[DimSH]
[MonSH]
2 Kox [DimSH][GSSG]
[DimSS][GSH]
2
Kdim Kox
 
 
The two steps in scheme 1 are linked but depend differently on the peptide 
concentration: the dimerization step (Kdim) is a reversible bimolecular association 
reaction that depends on the reduced monomer concentration (MonSH); the subsequent 
oxidation step (Kox) is also reversible, but independent of the concentration of the peptide 
and dependent on the ratio of oxidized (GSSG) to reduced glutathione (GSH). Using this 
function we fit curves to obtain the parameters Kdim and Kox for each MS1 variant (Table 
3.2; Figure 3.4, 3.5A). Comparison of ∆Gdim for each variant suggests that the amino acid 
in the a position aids the association of membrane helices in increasing order of: Gly > 
Ala > Val > Ile, in good agreement with the AUC data. Clearly, the association of the 
helices increases as the size of the core positions side chain decreases. 
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Figure 3.1 Helical wheel (A), computational model showing side and top view (B), and 
sequence of MS1 variants (C). MS1, -Gly, -Ala, -Val, and –Ile are N-terminally Cys-
modified. –Gly-(Ct) is C-terminally Cys-modified. The variable a positions are shown in 
green, and the Leu at d in red.  All peptides had an N-terminal acetyl group. 
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Figure 3.2 CD Spectra of MS1 variants (units are deg cm
2
 dmol
-1
 res
-1
).  The spectra 
show that all peptides are predominantly α-helical at a peptide/detergent ratio of 1/1000 
or 1/50 (matching the concentration range for the thiol-disulfide exchange equilibria). 
The magnitude of the ellipticity at 222 nm is the same within the experimental error, 
which derives primarily from the concentration determination used to compute the mean 
residue ellipticity.  Buffer conditions and other methods are given below. 
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Figure 3.3 Sedimentation equilibrium analysis of the reduced MS1 variants in DPC 
micelles: (A) MS1-Gly, (B) MS1-Ala, (C), MS1-Val, (D) and MS1-Ile. The absorbance 
was measured at 280nm. The top panels shows the residuals of single species fitting to 
data at respectively 30, 35, 40, 45, 48 KRPM. (E) MS1-Ala is fitted with monomer-dimer 
equilibrium, resulting in pKdim equal to -1.3.  In this analysis the concentration of peptide 
is mole ratio of peptide/detergent, and hence is unitless. (F) Monomer/dimer species 
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distribution of MSI-Ala as a function of peptide/DPC ratio based on fitting in (E). Buffer 
conditions and other methods are given below. 
 
Table 3.1 Association states of MS1 variants determined by AUC 
 Observed MW Monomer MW Ratio
a 
MS1-Gly 6300±600 3214.4 2.0±0.2 
MS1-Ala 5600±200 3270.5 1.7±0.1 
MS1-Val 3200±300 3359.3 1.0±0.1 
MS1-Ile 3100±500 3438.8 1.0±0.2 
a 
 Ratio = Observed MW / monomer MW 
 
Table 3.2 pKdim and pKox obtained from analysis of data in Figure 3.2A 
 pKdim pKox ∆Gdim (Kcal/mol dimer)_ 
MS1 -2.6 1.5 -3.6 
-Gly -3.0 2.6 -4.1 
-Ala -1.6 1.2 -2.2 
-Val  0.9 -0.8 1.2 
-Ile  1.9 -2.0 2.6 
The error is estimated to be approximately 10% based on the error in experimental 
concentrations of the reduced and oxidized peptides 
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Figure 3.4 Simulation of disulfide exchange equilibrium related to various dimerization 
affinities (Kdim) and redox ratios (Kox). The figure shows theoretical fractions of 
crosslinked dimer as a function of peptide/DPC ratio at (A) varying pKdim (pKox=0), and  
at (B) varying pKox (pKdim=0).  Note that the shapes of the curves vary depending on both 
parameters.  Thus, the figures demonstrates that thiol disulfide equilibrium method is 
sensitive to both the free energy of association as well as and redox potential for a given 
peptide. 
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Figure 3.5 (A) Analysis of the fraction of crosslinked dimer as a function of peptide/DPC 
ratios for each MS1/variant.  The theoretical curve describes the least-squares fit to 
scheme 1 (Table 3.2). The standard errors in the experimental points are similar for each 
peptide and are indicated for MS1-Ile (Others are not so shown for clarity). (B) HPLC 
chromatogram after redox equilibration of the C-terminal and N-terminal Cys-modified 
MS1-Gly mixture indicates that MS1-Gly prefers an anti-parallel orientation. The other 
peaks are glutathione adducts.  
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Interestingly, as the size of the side chain at the a position decreases, the ease of 
disulfide formation (reflected in Kox) becomes less favorable. This was surprising, given 
that the peptides have a Gly3 linker between the helical ends and the Cys. As long as the 
helices pack in a parallel manner, the flexibility of the linker should easily accommodate 
any subtle differences in helix-packing (two Cys-Gly3 linkers could extend up to about 
20 Å, while interhelical distances in dimers vary by only a couple Å). Thus, we 
considered the possibility that MS1-Gly prefers to assume an antiparallel orientation.  In 
this case, association of MonSH would remain favorable, but the oxidation step would 
require unfavorable intramolecular rearrangement of the antiparallel dimer, Dim(anti)SH, to 
the parallel Dim(parallel)SH to allow disulfide formation, because of the need to shift the 
equilibrium from one favoring antiparallel to parallel dimers upon disulfide formation 
(Scheme 2).   
 
Scheme 2.   
2MonSH [Dim(anti)SH DimSS
GSSG 2GSH
Dim(parallel)SH]  
 
To test this hypothesis, we synthesized a C-terminally Cys-modified peptide 
(Figure 3.1C, -Gly-(Ct)), which was mixed in equal amounts with N-terminally Cys-
labeled MS1-Gly under reversible redox conditions.  If MS1-Gly has the same preference 
to form parallel dimers as antiparallel dimers, then a ratio of 1:1:2 (N-terminal 
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homodimer : C-terminal homodimer : heterodimer) is expected.  However, the 
experimental ratio is 1:1:14, indicating that MS1-Gly strongly prefers to form anti-
parallel dimers (Figure 3.5B).  
 
To probe further the orientation of MS1-Gly and the other variants, the peptides 
with N-terminal Cys residues were individually air-oxidized to force an N-terminal 
crosslink (Figure 3.6, 3.7). Under these conditions peptides with a strong tendency to 
form antiparallel dimers might be expected to oligomerize as shown in Figure 3.3C. To 
avoid the precipitation of polymers during centrifugation we performed the experiment 
on samples that were approximately (75±5)% oxidized. The ratio between the computed 
molecular weight from a single-species fit and the computed monomeric molecular 
weight roughly reflects the degree of oligomerization (Table 3.3). The computed ratio for 
MS1-Gly is 6.9, supporting the expectation that MS1-Gly prefers an anti-parallel 
orientation. MS1-Ala has a ratio of about 3, in agreement with the conclusion that this 
peptide prefers to form weak, antiparallel dimers. The ratio for MS1-Val and MS1-Ile is 
less than two, again consistent with the suggestion that they form even weaker parallel 
dimers. Thus, as the side chains in the core positions become smaller, the helices prefer to 
form antiparallel orientation. 
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Figure 3.6 Analytical ultracentrifugation of approximately 80% disulfide-bonded MS1-
Gly (A) and MS1-Ile (B).  The greater degree of curvature in panel A vs. B is indicative 
of greater oligomerization. (C) Oligomerization of MS1-Gly and MS1-Ala via formation 
of antiparallel dimers. 
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Figure 3.7 Sedimentation equilibrium analysis of the MS1 variants in DPC micelles: (a) 
MS1-Ala and (b) MS1-Val. Absorbance is measured at 280nm. Top panels shows 
residuals of single species fitting to data at respectively 30, 35, 40, 45, 47 KRPM. 
Peptides were first air-oxidized in buffer. The percentage of air oxidized dimer was 
determined by analytical HPLC to be (75±5)%. Buffer conditions and other methods are 
given below. 
Table 3.3 Degree of association of air-oxidized MS1 variants in DPC micelles 
determined by analytical ultracentrifugation 
 Observed MW Monomer MW Ratio
a 
MS1-Gly 22200±800 3214.4 6.9±0.1 
MS1-Ala 9200±1200 3270.5 2.8±0.4 
MS1-Val 5000±1700 3359.3 1.5±0.5 
MS1-Ile 4300±1300 3438.9 1.3±0.4 
a
 Ratio defined as in Table 3.1 (Main text).  The errors are large for low observed MW, 
due to the small curvature in the radial distribution curves, adding uncertainty in the fitted 
baseline parameter. 
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To investigate the energetic and structural mechanisms behind these observations 
we built parallel and antiparallel computational models for the MS1 variants. While long 
simulations in bilayers would be essential to fully evaluate the relative energetic 
contributions from helix-helix, helix-lipid and lipid-lipid components, successful 
models
186
 and designs
82
 of transmembrane proteins have been achieved by probing helix-
helix packing interactions alone, using a much simpler gas phase potential energy 
function. For each sequence, the conformational space available to parallel and 
antiparallel two-stranded coiled coils (Figure 3.8A) was globally searched using a 
molecular mechanics force field to compute the difference in energy between the 
homodimer versus the isolated monomers as described in the supplement. The resulting 
energy landscapes (Figure 3.8B) have global minima corresponding to structures in 
which the variable a position projects towards the core of the structure as in Figure 3.1B. 
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Figure 3.8 (A) Sampling Crick parameters for parallel (r, θ) and anti-parallel (r, θ, z-
translation) dimers. (B) Energy landscape showing the difference in computed Leonard-
Jones energy ELJ (for the dimer versus two monomers) of MS1-Gly in a parallel 
orientation.  The minimum in the surface has a helical phase (θ) of 154°, allowing 
packing of the Gly residues at the helix/helix interface as in Figure 3.1B.   
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The calculations are in remarkable agreement with experiment, given the stark 
simplicity of the calculations.  The global minimum energy conformations (GMEC) for 
MS1-Gly and MS1-Ala correspond to antiparallel structures, which also allow the closest 
approach of the helices (Table 3.4). By contrast, the GMEC conformations for MS1-Val 
and MS1-Ile, correspond to parallel structures.  To gain insight into the interactions 
responsible for these structures, some of the energetic components were investigated, 
specifically the change in Leonard-Jones energy (ΔELJ, approximating the van der Waals 
component) and the electrostatic term associated with interactions between the partial 
charges of the main chain atoms at the interface (ΔEbb). The values of ΔELJ for the 
GMEC structures correlate with the experimental ranking (∆Gdim), both in terms of 
overall energetics of association as well as the preference for parallel versus antiparallel 
structures (Table 3.5). Moreover, although the magnitude of ΔEbb depends on the 
electrostatic treatment employed in these calculations, there is a clear trend towards 
greater stabilization of the antiparallel structure as the residues at the a position (and 
hence the inter-helical separation) become smaller.  
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Table 3.4 Energetic contributions for minima in energy landscape 
a
 
Peptide
 
Parallel
 
Anti-Parallel
 Δ(orientation) b 
MS1-
 Δ ELJ
 Δ Ebb Δ ELJ Δ Ebb Δ Δ ELJ Δ Δ Ebb 
Gly -23.5 2.8 -38.0 -1.4 -14.6 -4.2 
Ala -31.8 1.8 -36.1 -0.9 -4.3 -2.7 
Val -35.2 0.8 -26.2 -1.0 9.1 -1.8 
Ile -32.3 0.4 -28.8 -0.1 3.5 -0.5 
a  
Units are kcal/mol based on the CHARMM Force Field.  Values in bold give the values 
of Δ ELJ and Δ Ebb associated with the GMECs. 
b
 Δ(orientation) represents the energetic 
difference between the global minimum for the anti-parallel vs. parallel orientations.  
 
Table 3.5. Crick parameters at the potential energy minimum 
Peptide Parallel Anti-Parallel 
MS1- R(Å) θ(º) R(Å) θ(º) Ztrans(Å) 
Gly 4.3 154 3.6 130 -2.1 
Ala 4.4 152 4.3 135 -1.4 
Val 4.6 154 4.5 145 -1.8 
Ile 4.9 146 4.8 150 -1.2 
See Figure 3.8A (main text) for description of parameters 
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3.4 Conclusion and Discussion 
These studies together with other studies of MS1 variants
77
 show that small 
residues at TM helix-helix interfaces allow helices to come into close contact, 
concomitantly increasing their van der Waals interactions.
80, 180
  Thus, they are in 
agreement with previous studies highlighting the importance of van der Waals 
interaction,
178
 while also demonstrating the important role that small residues can play in 
allowing particularly efficient packing to occur.  Finally, we show that close interhelical 
distances associated with packing of small sidechains can additionally facilitate 
interhelical electrostatic interactions between the partial charges of backbone atoms. 
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3.5 Methods 
Peptide synthesis and purification 
Peptides were synthesized as C-terminal carboxamides at a 0.1 mmole scale on 
RINK amide resin (Novabiochem) by N-9-fluorenylmethyloxycaronyl (Fmoc) amino 
acids (four-fold molar excess) on a Symphony peptide synthesizer. Standard coupling 
conditions are shown in ref.
141
  
 
Side chain deprotection and simultaneous cleavage from the resin was performed 
using a mixture of trifluoroacetic acid (TFA)/water/triisopropylsilane/1, 2- ethanedithiol 
(92.5/2.5/2.5/2.5) and precipitated with cold diethyl ether.  The peptides were purified by 
reverse phase HPLC using a preparative (Vydac, C4 column, 250mm x 9.4mm i.d.) in a 
gradient between solvent A (water with 0.1% TFA) and solvent B (isopropanol 
/acetonitrile 2:1 with 0.1% TFA).  The purity of the peptides was confirmed by analytical 
reverse phase HPLC (Vydac C4 column) and MALDI-TOF mass spectrometry (Voyager 
model DE RP; PerSeptive Biosystems). 
 
Preparation of peptide detergent micelles 
MS1/variants and detergent dodecylphosphocholine (DPC) were dissolved in 
2,2,2-trifluoroethanol (TFE) and mixed in a glass vial. The TFE was removed under a 
stream of nitrogen and subsequently in vacuum. The samples were re-hydrated with 
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100mM Tris–HCl (pH 8.6), 100 mM KCl and 1 mM ethylenediaminetetraacetic acid 
(EDTA) unless noted otherwise. 
 
Circular dichroism 
CD spectra were acquired with a Jasco J-810 spectropolarimeter and a 0.1 cm 
quartz cell at 25℃.  50μM MS1/variants were incorporated in DPC at detergent/peptide 
molar ratios of 50 and 1000.  CD measurements were carried out in aqueous buffer 
containing 2.5 mM Tris–HCl (pH 8.6), 2.5 mM KCl and 25 μM EDTA. The CD spectra 
were averaged over three scans using a 1 nm step.  Baseline obtained by DPC in buffer 
was subtracted from all peptide spectra. 
 
Thiol-disulfide exchange equilibria with glutathione redox buffer  
Thiol-disulfide exchange was conducted as described in reference.
141
 25 μM 
MS1/variants were incorporated into DPC at different DPC/peptide ratios from 50 to 
1000. The samples were incubated in a reversible redox condition of a glutathione buffer 
containing 0.45 mM oxidized (GSSG) and 1.05 mM reduced (GSH) glutathione for 4 
hours to reach equilibrium, followed by quenching with HCl at final concentration of 
0.12 M. The mixtures were separated by analytical RP-HPLC and each peak was 
identified by MALDI. The area of the peak was converted into mass using standard 
curves.  
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The data in Figure 3.2A are presented as a plot of cross-linked dimer fraction as a 
function of peptide/DPC ratio, fitted by IGOR Pro (Wavemetrics) using functions derived 
from equilibrium scheme 1 (see main text), resulting in minus log of the association 
constant (pKdim and pKox) for all MS1/variants.  
 
The experimental observables are the concentrations of the reduced and oxidized 
species. The HPLC assay does not distinguish between MonSH and DimSS so the total 
concentration of reduced species, [PepSH], is given by the sum of [MonSH] and 2[DimSH]. 
Glutathione adducts are also observed, but are generally much lower in concentration, 
and can be neglected because the equilibria of interest required to compute Kdim and Kox 
involves only the concentration of the reduced species (MonSH  plus DimSH) as well as 
DimSS at equilibrium. 
PT = [PepSH] + 2[DimSS]                 eqn: S1a 
PT = [MonSH] + 2[DimSH] + 2[DimSS]               eqn: S1b 
PT = [MonSH] + [MonSH]
2
 Kdim + [MonSH]
2
 Kdim
.
Kox
.
[GlutSS]/[GlutSH]
2               
eqn: S1c
                                                     
 
Equation S1c was solved numerically for [MonSH] as a function of [PT], Kdim, Kox, 
and [GlutSS]/[GlutSH]
2
 using the root-finding algorithm in IGOR Pro.  [PT] and 
[GlutSS]/[GlutSH]
2
 are experimentally determined quantities, leaving only Kdim and
  
Kox as 
dependent variables. The data are then expressed as a plot of fraction of the peptide in the 
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disulfide form (frac = 2[DimSS]/PT), and the values of the dependent variables obtained 
by non-linear least squares fitting to the equation: 
frac = {[MonSH]
2
 Kdim
.
Kox
.
[GlutSS]/[GlutSH]
2
}/PT + C   
in which C is a constant, which was found to be close to zero for all peptides. 
 
Disulfide formation between MS1-Gly and MS1-Gly-(Ct) 
Also, in order to measure the orientation of Gly-variant dimer, 12.5μM MS1-Gly 
and 12.5μM MS1-Gly-(Ct) (see Figure 3.1 in main text) were incorporated into DPC in a 
ratio of 1:100. Disulfide cross-linking experiments were applied for 24 hours with 
GSSG/GSH ratio of 1:4 and total concentration of 1.5 mM, followed by analytical HPLC.   
 
Analytical ultracentrifugation 
Sedimentation equilibrium experiment and data analysis were described as in 
refs.
82, 141
 The experiments were conducted at 25 ℃ using a Beckman XL-I analytical 
untracentrifuge at respectively 30, 35, 40, 45, 48 KRPM. 200 μM of each MS1 variant 
was incorporated into 20 mM DPC, in a buffer containing 100mM Tris–HCl (pH 8.6), 
100 mM KCl, 1 mM EDTA. Two groups of sample preparation were employed for 
different purposes.   
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In order to measure the oligomerization of reduced MS1 variants, 1mM Tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) was added to buffer to keep the peptides 
reduced and buffer containing 48% D2O is used to density match the detergent. 
Additional multiple conditions of MS1-Gly were run at 333 μM peptide in 20 mM DPC 
and 100 μM peptide in 20 mM DPC in order to make sure MS1-Gly adopts a fully dimer 
conformation.  
 
In order to measure the orientation of MS1 variants, samples were air-oxidized 
overnight before sedimentation. Buffer containing 48% D2O is used to density match the 
detergent. The oxidation percentage is quantitatively measured (70±5)% by analytical 
HPLC after sedimentation.  
 
Data obtained were globally fitted by nonlinear least-squares curve by IGOR Pro 
(Wavemetrics) as previously described.
157
 Peptide partial specific volumes and the 
molecular mass calculated for 48% D2O exchange were calculated using previously 
described methods.
187
 The solvent density (1.0621 g/ml) and aqueous solution molar 
extinction coefficients at 280 nm were calculated using program Sednterp. These 
coefficients were multiplied by the molar detergent concentration to provide molar ratio 
concentration units. All these values were kept constant during global fitting.  
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Computational modeling. 
The original MS1 peptide was designed using GCN4‟s backbone as a template, 
which is a parallel coiled coil.
60
 In this work, we model the MS1 variants using a coiled 
coil description of the backbone. To generate the coiled coil backbones, we used Crick‟s 
equations.
188
  For the parallel coils, the super-helical radius and the α-helical phase were 
varied to generate the model backbones. For anti-parallel coils, the super-helical radius, 
the α-helical phase and the z-Translation were varied to generate the model backbones.  
For coiled coils of this size, some of the degrees of freedom can be held at constant 
values.
161
  The pitch was set to 190 Å. The rise per residue was set to 1.51 Å. The α-
helical radius was set to 2.25 Å. The α-helical frequency was set to 102° (360° / 3.5 
residues per turn). For computational efficiency, we modeled the MS1 sequence starting 
at the residue prior to the first variable a position and including a total of 16 residues 
(Figure 3.1). This is the most hydrophobic region, which should correspond to the 
transmembrane portion of MS1. 
 Sampled Ranges 
Degree of Freedom Parallel Antiparallel 
super helix radius (r) 2.5 – 8 Å; steps of 0.1 Å 2.5 – 7.5 Å; steps of 0.1 Å 
α-helix phase (θ) -180° – 180°; steps of 5° -180° – 180°; steps of 5° 
Z-translation (z) N/A -3 – 3  Å; steps of 0.1 Å 
 
To complete the models of each MS1 variant, the side-chains needed to be built 
on the backbone.  Each side chain, except for alanine and glycine, was modeled using 30 
conformations from an energy-ranked rotamer library.
189
 The energy of each side-chain 
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conformation with the backbone and each pair of side-chain conformations was 
computed using an implementation of the CHARMM force field,
190
 including IMM1 
membrane solvation.
148
 To select the proper rotamer at each position, the CHARMM 
energy table was processed by an Integer Linear Programming (ILP) optimization 
algorithm.
191
 Our C++ implementation of the algorithm uses the Gnu Linear 
Programming Toolkit (GLPK)
192
 to solve for the global minimum energy configuration 
(GMEC) of side-chains. Lastly, each model was minimized using CHARMM. The 
minimization was run for 1000 steps, using the Adopted Basis Newton-Raphson 
algorithm and restrained by placing harmonic forces on the backbone Cα atoms. 
 
In order to evaluate the association energy, the energy of an isolated, ideal and 
independently repacked helix was used as a reference, unbound state. The single helix for 
each MS1-variant sequence was modeled using the exact same protocol as stated above. 
 
 
To understand further the role of electrostatics in membrane proteins, we computed the 
contribution of the interfacial residues backbone atoms (the residues that are varied in 
this study) in both the winning parallel and anti-parallel models.  Because we are 
interested only in the rank-ordering of the electrostatic contributions, the dielectric was 
set to 1. All MS1-variant sequences preferred their anti-parallel model for electrostatics 
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(based on the minimum-energy conformations of the parallel and antiparallel 
conformations). However with larger residues at the interface the difference had a 
marginal preference (Figure 3.9).  
 
Figure 3.9 Electrostatics contribute to the orientation preference of MS1 variant models. 
The difference between electrostatic energy in the parallel and anti-parallel models 
correlates with inter-helical distance (average of parallel and anti-parallel distances). The 
glycine model shows the largest electrostatic energy difference between parallel and anti-
parallel orientations. 
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3.6 Contributions 
Yao Zhang performed all the experiments and related analysis in this chapter, 
Daniel W. Kulp performed the computational modeling. 
This chapter has been published in Journal of the American Chemical Society, 
2009:131(32):11341-3. 
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4 Chapter 4: pH-switchable peptide model for membrane 
insertion and pore formation 
 
4.1 Abstract 
As therapeutic potentials for macromolecules, like peptides and proteins, are 
increasingly characterized, there is a need to develop the means to deliver them in to the 
cytosolic environment (where these agents carry out the expected functions) across the 
hydrophobic barrier of membrane. Efforts to develop a variety of intracellular drug 
delivery systems as viral vector, lipoplexes, nanoparticles and amphiphilic peptides have 
been made, but various challenges as delivery efficiency, toxicity and controllability 
remain to be overcome. Here we have designed and characterized a series of pH-
switchable pore formation (PSPF) peptides as a potential delivery agent. Successful low 
pH-triggered, PSPF-mediated release specific for ATP and miRNA from red blood cells 
was characterized.  Furthermore, various biophysical studies (Trp fluorescence, CD, SEC, 
AUC and ATR-FTIR) show that the decreased pH destabilizes the PSPF stability in 
aqueous systems while promoting their membrane insertion. Together, these results 
suggest a model that reduced pH drives PSPF to insert into membrane, leading to target-
specific escape through pore formation.  
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4.2 Introduction 
The ability to introduce targeted substances into a cell‟s interior would greatly 
enhance our ability to interface with cellular processes.
160, 193
 Though for a small class of 
molecules cellular uptake can be spontaneous, the general task, known as the delivery 
problem, is largely unsolved.
193, 194
 This is because biological membranes serve as 
effective barriers that prevent most substances from freely flowing into and out of cells 
and between organelles. To allow flux of desired target, organisms depend on membrane-
inserted protein channels and transporters. Thus a potential solution to the delivery 
problem is via engineering of custom channels or transporters. 
 
In nature, a common feature of these carrier proteins is their controllability. A 
channel or transporter responsible for the flux of an important molecule can generally be 
activated or inactivated by the cell as needed.
195
 For example, channel-forming toxin 
peptides, found in each of the three domains of life, generally become active after a 
proteolytic cleavage event.
196
 This is also a desirable feature in engineered carrier 
proteins as controlled delivery could lead to targeted delivery in pharmaceutical 
applications.  
 
Here we aim to design peptides that bind to biological membranes and form pores 
only at low pH, but are minimally interactive at high pH. The pores can serve as channels 
for transport of appropriately-sized target, while the pH switch provides a convenient 
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manner in which to control the activity. Further, because of the lower pH environment in 
the endosome, the uptake of such peptides by endocytosis could allow endosomal escape 
of material present in the extracellular environment into the cell. 
 
To realize this pH-switchable behavior, we considered three thermodynamic 
states in our design process (Figure 4.1). At high pH, the peptide should be “stored” in a 
water-soluble form that does not interact with the membrane. A good way to encode this 
is to assure the formation of a stable water-soluble helical bundle at high pH. Lowering of 
pH should destabilize this state, allowing peptide monomers to interact with the 
membrane. Here we consider either a surface-adsorbed form, in which helical monomers 
are engaged with the membrane surface, or a fully inserted state capable of forming a 
channel. Because insertion and channel formation are thermodynamically linked, the 
relative stability of the inserted versus surface-adsorbed states will have a concentration 
dependence, with higher peptide concentrations favoring insertion and channel formation. 
 
To minimize membrane association at high pH, the water-soluble bundle should 
be very stable and its exterior should interact more favorably with water than the 
membrane at these conditions. The most hydrophobic and potentially membrane-
interacting region of the peptide is buried in the core in this state. At low pH, both of 
these factors ideally need to be reversed - the stability of the water-soluble bundle should 
decrease, producing a population of dissociated monomers poised to interact with the 
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membrane, while the hydrophobicity of the peptide (and thus its preference to interact 
with the membrane) should increase. 
 
 
Figure 4.1 The desired free energy diagram of the designed peptide as a function of pH. 
Lowering pH should destabilize water-soluble bundle state and stabilize first membrane-
associated monomeric state and then, in a concentration-dependent manner, the 
membrane-inserted channel state. 
 
We achieve this pH modulation of stability and hydrophobicity by including 
amino acids in the peptide sequence whose charge state and hydrophobicity are pH-
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dependent, such as Asp, Glu and His, and considering the stability of the water-soluble 
coiled coil-like bundle. In addition, we must also consider the specific inter-residue 
interactions of the membrane-inserted pore in selecting the design sequence, as we are 
interested in stabilizing a specific pore-forming state at low pH, rather than simply 
ensuring membrane insertion. For example, peptides that simply insert into membranes or 
those that insert and form indiscriminately large pores or even cause lysis are abundant in 
nature,
197
 but would constitute unsuccessful endpoints of our design efforts either because 
of lack of pore formation or potential toxicity. Thus, the overall design procedure 
combined the use of pH-switchable residues with the consideration of inter-residue 
contacts and stabilities of both the water-soluble as well as membrane-inserted pore states. 
 
Here, we present the design and characterization of a series of pH-switchable pore 
formation (PSPF) peptides. Several of the designed peptides associate with the membrane 
in a pH dependent manner.  The most promising peptides also show features of pH 
dependent pore formation.  
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4.3 Results 
Rational selection of amino-acid choices 
The design goal was to create a water-soluble peptide that associates into a stable 
coiled-coil bundle at high-to-neutral pH, while preferring a membrane-inserted channel 
state at low pH. This means that upon pH decrease, the nonpolar residues facing inward 
in the soluble bundle, should invert and face the lipid phase in the membrane-inserted 
channel (Figure 4.2). Since canonical coiled coils have only seven environmentally 
distinct positions, referred to as the heptad and designated with letters a though g (Figure 
4.2A), we focused on choosing the appropriate amino-acids for each of these seven sites. 
Furthermore, each site in our design must play two roles - stabilizing the water-soluble, 
“hydrophobic-inside” state at high pH and the membrane channel, “hydrophobic-outside” 
state at low pH. To impart stability on the water-soluble bundle, we chose to adhere to the 
canonical Leu-zipper coiled-coil motif, meaning that coiled-coil positions a and d were 
set to Leu. These same residues face the lipid phase in the membrane channel state, and 
Leu residues are ideal for this task as well (Figure 4.2B). The solvent-exposed b, c, and f 
positions in the water-soluble bundle should be polar to impart solubility and fold 
specificity, and these can also be used to modulate bundle stability through their innate 
helix propensities. In the membrane-channel state, these positions are also water-facing, 
as they point into the center of the channel, so their polar nature is appropriate here as 
well. However, unlike in the water-soluble state, b and c positions are also located at the 
inter-helical interface of the channel. Thus, the importance of these positions goes beyond 
their physico-chemical character and includes potential interactions stabilizing specific 
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interfacial conformations of channel helices. The inter-helical geometry in the channel 
state is important as it ultimately defines the shape and even size of the entire channel. 
 
 
Figure 4.2 The design concept illustrated using one of the designed sequences (PSPF-
DKG). Hydrophobic residues are either lining the bundle the core in the water-soluble 
state (A), or are facing the lipid membrane in the membrane channel state (B). Dotted 
circles illustrate potential hydrogen bonding in the channel state. Heptad positions in both 
panels are labeled according to the water-soluble state. The amino acid choices at each 
position are shown in Table 4.1. 
 
At the f position, we chose to consider Lys or Gln - amino acids with favorable 
helix propensities
198
 that are common at this position in coiled coils. At position b we 
considered Ser because of its polar nature and relatively high helix propensity, as well as 
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due to its high preponderance in closely-packing helix-helix interfaces in TM proteins.
75
 
The c position was chosen as the pH-sensing switch. We considered amino acids Glu and 
Asp at this position as their protonation state is dependent on pH, causing them to be 
more protonated, less charged and thus more hydrophobic at lower pH. Although the pKa 
of the carboxylic side-chains groups of Glu and Asp in water are around 4.0, somewhat 
lower than the typical endosomal pH or ~5.5, significant shifting in protonated 
populations would still be expected relative to neutral pH, and the collective effect of 
having multiple closely-spaced acidic groups on one face of a helix will likely increase 
the effective pKa of the side-chains. An additional significance of Glu and Asp residues 
is their potential ability to participate in inter-helical hydrogen bonding (see Figure 4.2B), 
thus further dialing in a specific, closely packed inter-helical geometry in the membrane-
channel state (see also structural modeling below). As a way of testing the importance of 
the pH switch residue, we also considered the amino acid His at the c position. The side-
chain of His titrates at pH ~6.1, but it is more charged at acidic pH than at neutral pH. 
Because of this reversed pH sensitivity compared to Asp and Glu, His provides a 
convenient point of reference. 
 
Positions e and g are located along the helix-helix interface in both the water-
soluble and the membrane-channel states. Because the primary driver of the water-
soluble bundle stability is the canonical leucine-zipper motif, we opted to choose small 
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hydrophobic residues at e and g with the primary purpose of stabilizing a closely-packed 
TM helical interface
75
. 
 
Table 4.1 Amino-acid choices considered in design 
Position 
in water 
Function in water, 
high pH 
Position 
in membrane 
Function in membrane, 
low pH 
Amino acid 
Choice 
a Helical bundle 
hydrophobic core 
b Membrane-facing. Leu 
b Solvent-exposed, 
imparts solubility. 
d Small residue for helical 
interface, potential inter-
helical hydrogen bonding. 
Ser 
c Solvent-exposed, 
imparts solubility. 
e Trigger residue, changes 
protonation state/ 
hydrophobicity at low pH. 
Potential inter-helical 
hydrogen bonding. 
Asp, Glu, 
His 
d Helical bundle 
hydrophobic core. 
f Membrane-facing. Leu 
e Modulation of 
helical propensity. 
g Small residue for helical 
interface. 
Ala 
f Solvent-exposed, 
imparts solubility. 
a Solvent-exposed in channel 
state (inner channel lining). 
Imparts folds specificity by 
encoding helical 
orientation preference. 
Lys, Gln 
g Modulation of 
helical propensity. 
b Small residue for helical 
interface. 
Ala, Gly 
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Based on the criteria list above, a group of sequences has been generated for the 
pH-switchable pore formation (PSPF) peptide (Table 4.2). 
 
Table 4.2 The sequence of PSPF peptides 
 
 
 
 
                          
 
In the column of peptide names, the heptad position for the membrane-soluble form is 
labeled after the one-letter amino acid code at top, and the heptad position for the water-
soluble form is label after the one-letter amino acid code at bottom. 
 
 
 
 
 
Peptide Sequence 
Heptad membrane 
PSPF-DQA                     
PSPF-DQG 
PSPF-DKA 
PSPF-DKG 
PSPF-EQA 
PSPF-EQG 
PSPF-EKA                     
PSPF-EKG                     
PSPF-HQA                     
PSPF-HQG                     
PSPF-HKA 
PSPF-HKG 
Heptad Water 
cdefgab cdefgab cdefgab cdefgab 
WSDLAQA LSDLAQA LSDLAQA LSDLAQA 
WSDLAQG LSDLAQG LSDLAQG LSDLAQG 
WSDLAKA LSDLAKA LSDLAKA LSDLAKA 
WSDLAKG LSDLAKG LSDLAKG LSDLAKG 
WSELAQA LSELAQA LSELAQA LSELAQA 
WSELAQG LSELAQG LSELAQG LSELAQG 
WSELAKA LSELAKA LSELAKA LSELAKA 
WSELAKG LSELAKG LSELAKG LSELAKG 
WSHLAQA LSHLAQA LSHLAQA LSHLAQA 
WSHLAQG LSHLAQG LSHLAQG LSHLAQG 
WSHLAKA LSHLAKA LSHLAKA LSHLAKA 
WSHLAKG LSHLAKG LSHLAKG LSHLAKG 
abcdefg abcdefg abcdefg abcdefg 
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Cellular release assays  
Red blood cell (RBC) lysis assays have been used to screen the functional 
efficacy of the peptides upon delivery (Table 4.3). The release of ATP, miRNA and 
hemoglobin has been studied at both pH 7.5 and 5.4.  The peptide is designed to 
selectively deliver the nucleotides or ribonucleic acid, with sizes similar to ATP and 
miRNA, across the membrane only at pH5.5. The desirable peptide should also negate 
membrane disruption, as assessed by leakage of proteins such as hemoglobin at both pHs. 
Therefore the peptides were first screened for hemolytic activity at both pH 7.5 and pH 
5.4. None of the twelve peptides had hemolytic activity at either pHs. When screening for 
ATP and miRNA release at 5μM, PSPF-DQA, PSPF-DKG, and PSPF-EKG showed 
relatively high release percentage for ATP (more than 20%) and miRNA (more than 
10%) at pH 5.4, and also low release percentage at pH7.5 for both ATP and miRNA (less 
than 10%). Among the top three peptides screened out of RBC assays, PSPF-EKG has 
been further characterized to reveal the mechanism of action.   
 
 
 
 
 
 
102 
 
Table 4.3 RBC Lysis assay of PSPF peptides 
 
Peptide 
RBC Lysis Assay (% calculated compared to triton-x-100) 
Hemoglobin Release %ATP at 5μM %miRNA at 5μM 
pH7.5 pH5.4 pH7.5 pH5.4 pH7.5 pH5.4 
PSPF-DQA none none 3.81 17.91 0.81 18.61 
PSPF-DQG none none 3.21 8.61 0.06 0.16 
PSPF-DKA none none 4.64 5.79 4.13 0.79 
PSPF-DKG none none 7.54 24.1 5.54 7.47 
PSPF-EQA none none 3.69 3.61 0.46 0.02 
PSPF-EQG none none 3.36 9.52 0.15 2.64 
PSPF-EKA none none 2.02 3.66 0.51 0.21 
PSPF-EKG none none 3.38 27.3 0.14 12.54 
PSPF-HQA none none 6.17 11.72 0.02 1.43 
PSPF-HQG none none 5.69 10.55 0.2 0.64 
PSPF-HKA none none 0.93 5.7 0.43 0.02 
PSPF-HKG none none 32.1 39.22 72.28 0.44 
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Peptide engagement with the lipid bilayer by tryptophan fluorescence 
To detect the engagement of peptides with lipid vesicles, tryptophan (Trp) 
fluorescence was measured for PSPF-DQA, DKG and EKG. The extent of environmental 
change around the N-terminal Trp was determined by the observed shift and changes in 
intensity of the fluorescence signal. Blue shifts (Table 4.3), correspond to a more 
hydrophobic environment, such as that which would occur to the Trp upon membrane 
interaction or insertion. The majority of the PSPF- peptides studied showed minimal blue 
shifting at pH 7.4 and larger shifts at pH 5.5 (Table 4.4). PSPF-DQA shows small 
detectable shift at pH 5.5 (-1 nm), whereas PSPF-DKG and EKG show blue shifts of 
approximately 3 nm (350 to 347 nm) each at pH 5.5. PSPF-HKG also showed a 
significant shift from 351 to 341 nm at pH 5.5.  
 
Despite different experimental conditions, Trp fluorescence shifts among all the 
peptides correlate strongly with ATP release at pH 5.5, with R
2
 of 0.74 if linear 
regression is applied (Figure 4.3). At pH 5.5, a larger shift in Trp fluorescence (likely due 
to insertion into the membrane of Trp) corresponds to greater release of ATP (likely from 
membrane insertion and pore formation).  This suggests that the peptides are acting in a 
similar manner in both experimental assays and consistent with pH-sensitive insertion 
and pore formation. 
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Table 4.4 Trp fluorescence of PSPF- series peptides with various amounts of lipid 
vesicles. 
 
Peptide 
PSPF- 
pH7.4 pH5.5 
λmax (nm) Δ λmax % Intensity  
Increase* 
λmax (nm) Δ λmax % Intensity  
Increase 0 μM Lipid 200 μM Lipid (nm)# 0 μM Lipid  200 μM Lipid (nm) 
DQA 352 351 -1 32 348 347 -1 38 
DQG 354 353 -1 18 350 358 -2 33 
DKA 354 353 -1 18 349 358 -1 38 
DKG 355 351 -4 36 350 347 -3 38 
EQA 352 352 0 6 349 348 -1 21 
EQG 355 354 -1 15 349 346 -3 42 
EKA N/A N/A N/A N/A N/A N/A N/A N/A 
EKG 354 352 -2 28 350 347 -3 52 
HQA N/A N/A N/A N/A N/A N/A N/A N/A 
HQG N/A N/A N/A N/A N/A N/A N/A N/A 
HKA N/A N/A N/A N/A 349 347 -2 34 
HKG N/A N/A N/A N/A 351 341 -10 72 
# Δ λmax = λmax at 200 μM Lipid - λmax at 0 μM Lipid 
*% Intensity Increase = (Intensity at 200 μM Lipid - Intensity at 0 μM Lipid)/ Intensity at 
0 μM Lipid 
 
 
Figure 4.3 Correlation between ATP-release by PSPF peptides and the degree of lipid 
engagement as assessed by the fractional change of Trp-fluorescence signal upon 
addition of 200 uM lipid vesicles. 
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The association properties of PSPF  peptides in an aqueous system 
Size exclusion chromatography 
The association state of the designed peptide PSPF-EKG was initially investigated 
by size exclusion chromatography (SEC)
46
 using a Superdex 75 column (GE Healthcare) 
eluted at pH 7.4 (150 mM NaCl, 50 mM Tris) and pH 5.5 (150 mM NaCl, 50 mM MES) 
respectively. In addition, PSPF- DKG was also investigated to determine the effect of 
substituting Asp for Glu on the stability of the water-soluble bundle at each pH. To 
determine the approximate oligomerization states, four standards were used, shown by 
blue eluting peaks in Figure 4.4: blue dextran (2,000,000 g/mol), carbonic anhydrase 
(29,000 g/mol), cytochrome C (12,400 g/mol) and aprotinin (6,500g/mol). 
 
PSPF-EKG eluted with an apparent molecular weight 6.5-fold higher than the 
calculated molecular weight at pH 7.4 and 5.2-fold at pH 5.5 (Figure 4.4, Table 4.5), both 
as a single species. Noticeably PSPF-EKG presented a peak with significantly lower 
intensity and a broad trailing feature when eluting at pH 5.5, indicating that the decreased 
pH has increased the propensity to interact with column, which may act as a mimic of the 
membrane phase (Figure 4.4A). Dissociation during elution might also contribute to the 
peak shape, indicative of a lower stability of the water-soluble helical bundle.  Similarly, 
PSPF-DKG eluted with an apparent molecular weight 6.0-fold higher than the calculated 
molecular weight at pH 7.4 as a single species and nearly failed to elute at pH5.5 (Figure 
4.4A), indicating the lower pH drove the peptide to interact with the column. Furthermore, 
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the salt concentration has been increased to 2M and the shoulder of elution peak for 
PSPF-EKG still exists at pH 5.5 (Figure 4.4C, D). Also, Asp at the putative a position 
makes the PSPF-DKG more sensitive to the pH decrease than Glu in PSPF-EKG, in term 
of driving the peptide‟s preference away from the aqueous phase (Figure 4.4A). 
 
Figure 4.4 Size exclusion chromatography of PSPF-EKG and PSPF-DKG at each pH. 
Both PSPF-EKG and PSPF-DKG elute as a single species corresponding to the 
oligomerization of hexamer at pH 7.4 (B). PSPF-EKG elutes as a single-species peak 
with a significant shoulder at pH5.4 and the major peak corresponds to a formation of 
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hexamer. PSPF-DKG almost fails to elute at PH 5.5 (A). The salt concentration has been 
increased to 2M and the shoulder of elution peak still exists at pH 5.5 (C, D).  
 
Table 4.5 Apparent molecular weight and calculated oligomerization state based on size 
exclusion chromatography for PSPF- EKG and PSPF- DKG at both PHs 
 PSPF-EKG PSPF-DKG 
pH 7.4 pH 5.5 pH 7.4 pH 5.5 
Apparent MW 19,000 15,000# 17,000 N/A 
Oligomerization State* 6.6 5.2 6.0 N/A 
* Oligomerization State  = Apparent MW/ Monomer MW 
#
 Major peak  
 
Sedimentation equilibrium of analytical ultracentrifugation 
Analytical ultracentrifugation (AUC) sedimentation equilibrium
46, 53
 was applied 
to further investigate the association state and affinity of the water-soluble bundles of 
both PSPF- EKG and PSPF- DKG.  The peptides were studied at 100 μM peptide 
concentration and pH 7.4 (150 mM NaCl, 50 mM Tris) or pH 5.5 (150 mM NaCl, 50 mM 
MES). The parameters were globally fit to data collected over multiple rotor speeds (35, 
40, 45, 50 KRPM). Fitting the curve to a single MW species suggested an apparent 
molecular weights for PSPF- EKG of 18,000±30 at pH 7.4 (Figure 4.5A) and 16,000±30 
at pH 5.5 (Figure 4.5B). This agrees well with the data from size exclusion 
chromatography and points to a hexameric association state at both pHs for PSPF-EKG. 
The data can be further fit to a monomer-hexamer equilibrium, resulting in an association 
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energy ΔG of -6.3 kcal/mol monomer at pH 7.4 and -5.6 kcal/mol monomer at pH 5.5 
(Table 4.2). Also, as shown in the plot of species weight fraction, the concentration of 
peptide required to associate at pH 7.4 was lower than at pH 5.5 (Figure 4.5B, D). 
Together it suggests that decreased pH destabilized the helix bundle of PSPF- EKG. 
 
Figure 4.5 AUC sedimentation equilibrium of PSPF-EKG at pH 5.5 (A) and 7.4 (C). 
Single species fitting of PSPF-EKG suggests a hexameric association state at both pH 7.4 
(A) and pH 5.5 (C). For each peptide and pH condition, the top plot shows the single 
species fitting with residuals above while the below plot shows the species weight 
fraction. Then the data has been fit with a monomer-hexamer equilibrium model at both 
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pHs. The dissociation state and dissociation energy is shown in Table 4.6. The weight 
fraction distributions have also been plot for pH 5.5 (B) and pH 7.4 (D). 
 
For PSPF-DKG, a global fit resulted in a single-species apparent molecular 
weight of 17,000±30 at pH 7.4 (Figure 4.6A), which was 6.0-fold higher than the 
calculated molecular weight and again agrees well with size exclusion chromatography. 
The equilibrium of PSPF-DKG has also been fit into the equilibrium of monomer-
hexamer with association energy ΔG of -6.5 kcal/mol monomer (Table 4.6). The single-
species apparent molecular weight for PSPF- DKG at pH 5.5 was 24,000±60 (Figure 
4.6B). This could represent a heterogeneous set of association states, taken together with 
the broad elution peak observed in the size exclusion chromatography. 
 
 
Figure 4.6 AUC sedimentation equilibrium of PSPF-DKG at pH 5.5 and 7.4. Single 
species fitting of PSPF-DKG suggests it associates as a hexamer at pH 7.4 and reaches an 
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apparent molecular weight of approximately 24,000 at pH 5.5. For each peptide and pH 
condition, the top plot shows the single species fitting with residuals above while the 
below plot shows the species weight fraction.  
 
Table 4.6 Analytical ultracentrifugation (AUC) sedimentation equilibrium for PSPF-EKG 
and PSPF- DKG at pH 5.5 and 7.4. 
 PSPF-EKG PSPF-DKG 
 pH 7.4 pH 5.5 pH 7.4 pH 5.5 
Apparent MW 18,000±30 16,000±30 17,000±30 24,000±60 
Oligomerization State* 6.2 5.5 6.0 N/A 
-log(Kdissociation) 28.0±0.4 24.8±0.1 28.7±0.4 N/A 
Association ΔG# 
(kCal/mol monomer) 
-6.3 -5.6 -6.5 N/A 
* Oligomerization State = Apparent MW/ monomer MW 
#
 Association ΔG = 2.303*RT* log(Kdissociation)/6 
        
Circular dichroism and thermal denaturing 
Circular dichrosim (CD) suggests that PSPF-KEG adopts an alpha-helical 
secondary structure at both pHs (Figure 4.7).  
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Figure 4.7 Circular dichroism of PSPF-EKG suggests an alpha-helical secondary 
structure at both pHs.  
 
Furthermore, thermal denaturation by circular dichroism (CD)
199
 was used to 
study the thermal stability of the PSPF- EKG hexamer at multiple concentrations (2μM, 4 
μM and 20 μM), and at both pH 7.4 (Figure 4.8A) and pH 5.5 (Figure 4.8B). For each pH, 
to the curves were analyzed according to the Gibbs-Helmholtz Equation, using global 
least squares fitting of ΔHm, Tm and baselines. Tm was chosen as a global parameter 
defined with a reference concentration of 4 μM. ΔCp was also included, but over the 
range of experimental data examed, this parameter was not well defined.  
 
Gibbs-Helmholtz Equation:   ΔG=ΔHm(1-T/Tm)-ΔCp[Tm-T+T[ln(T/Tm)]]    
Here ΔG refers to the unfolding energy upon thermal denaturation, T refers to 
temperature, Tm refers to the melting temperature at which ΔG equals to zero. ΔHm refers 
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to the enthalpy at Tm, and ΔCp refers to the change in the heat capacity over the 
temperature range. 
 
 
Figure 4.8 Thermal denaturation of PSPF- EKG at pH 7.4 (A) and 5.5 (B). The data are 
fit to the Gibbs-Helmholtz Equation.  
 
The enthalpy at pH 7.4 is 22.0 kcal/mol monomer and is approximately 12% 
higher than at pH 5.5 (19.6 kcal/mol monomer) (Table 4.7). The value of enthalpy at both 
pHs are typical for designed water-soluble helix bundles.
200
 The melting temperature Tm 
is 339.0 K at pH 7.4 and is 5.6 K higher than at pH 5.5 (333.4K). The concentration of 
PSPF-EKG required to have 50% of the total amount of peptide remain folded at 300K 
was calculated to be 0.31μM at pH 5.5, which was approximately double the 
concentration of peptide required for 50% folding at pH 7.4 (0.14μM). These data suggest 
that decrease in pH destabilizes the folding of PSPF-EKG. 
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Table 4.7 Fitting results for CD thermal denaturation of PSPF- EKG at both pH 7.4 and 
pH 5.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
pH ΔH (kcal/mol monomer) Tm (K) [ PSPF-EKG ] at 50% fold and 300K 
7.4 22.0±0.1 339.0±0.1 0.14μM 
5.5 19.6±0.1 333.4±0.1 0.31μM 
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The structural properties of PSPF- peptides in a membrane micelle system 
Sedimentation equilibrium of analytical ultracentrifugation 
AUC sedimentation equilibrium of PSPF-EKG in detergent micelles pointed to a 
weak oligomerization at both pHs. PSPF-EKG was dissolved in N-tetradecyl-N,N 
dimethyl-3-ammonio-1-propanesulfonate (C-14 betaine) micelles. The density of the 
solution was adjusted by D2O to precisely match that of the C-14 betaine detergent at 
both pH 7.4 and pH 5.5 (50 mM sodium phosphate and 150 mM NaCl), so that only the 
peptide component contributes to the sedimentation equilibrium.
60, 139
 
 
Three samples prepared at different peptide-to-detergent ratios (1:50, 1:100, 
1:200) were each centrifuged at four rotor speeds (35, 40, 45, 50 KMRP) at each pH. The 
data could be fit into a monomer-trimer, monomer-tetramer, and monomer-higher 
oligomer equilibrium, suggesting that PSPF-EKG weakly associates in detergent micelle. 
Figure 4.9 showed an example in which a monomer-trimer equilibrium is fit to the data at 
pH 7.4 (Figure 4.9A) and pH 5.4 (Figure 4.9C), and the weight fraction distribution has 
been shown in Figure 4.9B and 4.9D.  
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Figure 4.9 The single-species fitting of AUC sedimentation in detergent micelles for 
PSPF-EKG at pH 7.4 (A) and 5.5 (C). Species weight fraction of PSPF- EKG at pH 7.4 
(C) and pH 5.5 (D) as the data were globally fit to a monomer-trimer equilibrium as an 
example.   
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The Orientation of PSPF- EKG in a Lipid Bilayer 
Attenuated total reflection IR spectroscopy 
The secondary structure and orientation of PSPF-EKG in deuterium oxide (D2O) 
hydrated bilayers were evaluated using attenuated total reflection IR spectroscopy (ATR-
IR).
143, 144, 201
 The IR spectra in the amide I region of the PSPF-EKG showed a single 
peak at 1656 cm
-1
, indicative of a dehydrated helical conformation in bilayers (Figure 
4.10). The dichroic ratio for parallel versus perpendicularly polarized light was 1.5. This 
order parameter would correspond to an orientation of approximately 75° relative to the 
membrane normal, assuming the bilayers are well ordered and the entire peptide is fully 
helical. The result suggests that the majority of peptide lies parallel to the lipid surface, 
and rules out the possibility of the peptide being oriented predominantly perpendicular to 
the bilayer surface.  The fact that the computed angle is less than 90° is also consistent 
with a small amount of peptide adopting a vertically inserted conformation, in 
equilibrium with the predominant form, although other models could also lead to the 
observed 75° angle. 
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Figure 4.10 ATR-IR of PSPF-EKG in phospholipids (POPC) bilayers. The peak at 1656 
cm
-1
 is indicative of alpha helical secondary structure. The orientation is demonstrated by 
the ratio of peak area of the 1656 cm
-1
 amide I bond for parallel (0°) versus perpendicular 
(90°) polarized incident light (relative to the membrane normal). 
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4.4 Conclusion and Discussion 
Therapeutic macromolecules such as peptides and proteins are easily cleared from 
the bloodstream and require assistance for intracellular delivery in order to reach their 
intended targets and achieve the desirable therapeutic effects. Decades of research effort 
have been devoted to develop delivery agents with high efficiency and low toxicity. 
202, 
203
 
 
Viral vectors are considered to be successful delivery agents and have been 
extensively studied for gene therapy. Viral vector based gene therapy has demonstrated 
promising results,
101
 but this potential life-saving delivery technique can also be risky. 
The death of a patient in the Paris trial suggests that viral vectors might also induce 
undesirable gene insertion and this potential danger is currently uncontrollable. 
204, 205
 
 
Most non-viral carriers are synthetic chemical conjugates. Active ingredients 
(drugs) are usually linked or enclosed into a vehicle and delivered into the cell via 
endocytosis or membrane fusion, or via a yet to be determined mechanism.
206, 207
 These 
vehicles are typically designed as liposomes/lipoplexes,
208
 cationic macromolecules 
polymer,
209
 polypeptide,
210
 and protein,
211
 amphiphilic polymer/polypeptide,
212
 
nanoparticles
213-215
  and cell penetrated peptides (CPP).
83
 Native sequences such as 
fusogenic peptide from viral fusion protein
216
 have also been manipulated as a cargo 
carrier to cross the barrier of cell membranes. A number of these approaches have also 
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entered clinical trials, but most of them reached a bottleneck due to high toxicity or lack 
of manipulability. 
207
 
 
Here, we have designed a series of pH-switchable peptides as potential candidates 
for intracellular (lysosomal) drug delivery. One of the top candidates, PSPF-EKG, has 
stood out from RBC lysis assay, in terms of highest target molecule delivery efficiency at 
selective pH (5.4). Lack of hemolytic activity ruled out the possibility of undesirable 
membrane description by PSPF-EKG at both pHs. Also, the nice correlation between 
ATP release at pH 5.5 and Trp-fluorescence at pH 5.4 upon lipid titration (Figure 4.3), 
indicates that membrane insertion presumably plays a key role in ATP release.     
 
RBC Lysis data also provide a direct comparison among all the designed peptides. 
Firstly, we have three options of pH-trigger residues in this peptide series. Asp and Glu 
residues both presented expected pH-switchable ATP and miRNA release in peptides 
PSPF-DQA and PSPF-DKG, indicating the carboxyl side chain groups respond 
efficiently to environmental pH change, though their intrinsic pKa of the unperturbed 
sidechain is around 4. The third trigger candidate, His, failed to show significant pH 
preferences in terms of ATP or miRNA release. However PSPF-HKG induced high ATP 
release percentage at both pHs. Presumably His will induce pore formation in a pH-
independent manner. Nevertheless, all the His variants ran into solubility issues in the 
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further biophysical characterization and thus are not considered as preferred candidates 
for further pharmaceutical development.  
 
Secondly, Lys and Gln have been chosen in f positions in order to provide helix 
propensities in aqueous system and solvent exposure surface in membrane system. The 
RBC lysis results did not discriminate between these two residues when comparing the 
performance of the aspartate and glutamate peptide variants (PSPF-EKG versus PSPF-
EQG, PSPF-EKA versus PSPF-EQA).  
 
The third screened parameter is the choice between Ala or Gly for residues 
packed in the helix interface. This part of the design was in light of previously discovered 
fact that small residues were preferred in TM helix interaction interface to stabilize the 
final folded state (TM helix bundle).
75, 139
 In the case of PSPF-EKG versus PSPF-EKA, 
Gly resulted in a much higher pH–switchable ATP and miRNA release. The results agree 
with the previous conclusion that Gly in TM helical interface drives stronger TM helix 
association that Ala,
139
 presumably because Gly stabilizes the helix interaction via weak 
Cα-H interaction.217 
 
A variety of biophysical assays have been applied in order to obtain a 
comprehensive mechanism of PSPF-EKG‟s pH switchable pore formation. We first 
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looked at the structural conformation and folding stability of PSPF-EKG in aqueous 
solution. CD, AUC and SEC suggest that PSPF-EKG forms a stable helix bundle at both 
pHs (Figure 4.11A), which is expected due to the designed canonical Leu-zipper coiled-
coil motif. AUC and thermal denaturing have been further used to study the folding 
stability difference between pH 7.4 and pH 5.5. The free energy of helix bundle has 
increased by 0.7 kcal/mol monomer upon pH decrease. Both ΔCp and Tm decrease at pH 
5.5 versus pH 7.4, suggesting that PSPF-EKG is better packed in higher pH. Also, in SEC 
PSPF-EKG presented a significant shoulder upon elution at pH 5.5 versus a sharp peak at 
pH 7.4. The shoulder did not disappear even as the salt concentration in buffer increased 
from 150 mM to 2 M. The data suggest pH decrease destabilizes the stability of PSPF-
EKG in aqueous system (Figure 4.11A, B), thus validating the first consideration of the 
original design.  
 
We characterized PSPF-EKG in micelles and bilayers. Equilibrium sedimentation 
AUC suggests PSPF-EKG adopts a monomer-oligomer equilibrium in C14-betaine 
micelles at both PHs (Figure 4.11C, D), with slightly higher stability at pH 5.5 than at pH 
7.4 (Figure 4.9B, D).  A unique oligomerization state could not be determined by AUC 
due to weak association. Furthermore, the orientation of PSPF-EKG has been studied by 
ATR-FTIR in POPC lipid bilayers. The average dichroic angle is about 75 degrees with 
respect to the lipid normal, revealing that the majority of peptides are in a membrane-
surface-absorbed state and adopt a vertical conformation with respect to the lipid normal. 
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This state presumably corresponds to the monomer state identified by AUC (Figure 
4.11C). Also, some of the peptides adopt a TM orientation, which might reflect a weakly 
associated oligomeric form (Figure 4.11D). This dynamic equilibrium between vertical 
monomer in membrane-surface-absorbed state and TM oligomer state, presumably 
induces membrane pore formation and plays a crucial role in ATP and miRNA release 
(Figure 4.11D).  
 
Figure 4.11 Model of PSPF-EKG membrane insertion and pore formation upon pH 
decrease. 
    
All the biophysical characterizations have corroborated a model for the 
mechanism of pH-controllable pore formation and ATP/miRNA release (Figure 4.11). 
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The primary future direction for enhancing the designs is to increase the population of 
TM peptide relative to the surface-absorbed state. There are two possible avenues that we 
will pursue towards this aim.  Firstly, the inter-peptide interactions in the TM state will 
be strengthened to favor oligomerization.  Secondly, the energetic cost of insertion into 
the bilayer will be decreased by modifying the hydrophobicity of these peptides. 
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4.5 Methods 
Hemolysis assay 
Hemoglobin 
Human Red Blood hemolysis assay was by carried out as described elsewhere
218
 
with modifications: 5 ml human blood from healthy individuals were transferred into a 50 
ml centrifuge tube and either resuspended in 35 ml buffer pH 5.4 (150 mM NaCl, 20 mM 
MES) or pH 7.5 (150 mM NaCl, 20 mM Hepes). Red Blood Cells (RBCs) were washed 3 
times with the appropriate buffer and finally resuspended in a total of 50 ml buffer (pH 
5.4 or 7.5). For the assay 175 μl of buffer solution (pH 5.4 or 7.5) was added into each 
well of a clear-bottom 96-well plate followed by 50 μl of resuspended RBCs (approx. 
2.5x10
7
 cells) in the appropriate buffer (for RBC transfer wide bore pipet tips were used 
to avoid cell damage). Test PSPF peptides (New England Peptide 
TM
) at the appropriate 
concentration were diluted in 25 μl PBS and then added to the cells. All steps were done 
with chilled buffers and on ice. The suspension was then mixed 6-8 times by pipetting 
with wide bore tips, the plate was covered and incubated at 37°C for indicated time. After 
incubation the cells were centrifuged for 5 min at 500 x g and 150 μl of the supernatant 
was transferred into a new 96-well clear-bottom plate. Absorbance at 541 nm was 
measured and hemolysis was normalized to RBCs which have been incubated in the 
presence of 1 % Triton X-100 (100 % hemolysis). 
 
Micro-RNA mir-16 
The release of micro-RNA mir-16 from RBCs was determined using stem-loop 
PCR as described elsewhere 
219. Briefly, 5 μl of supernatant was processed with TaqMan 
MicroRNA Cells-to-CT Kit (Applied Biosystems) according to manufacturers' protocol 
and quantitative PCR reaction was performed on an ABI (Applied Biosystems) 7500 Fast 
Real Time PCR System using standard cycling conditions 
220
. The derived Ct values for 
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mir-16 (Applied Biosystems cat. no.: 4373121) in each experiment were transformed into 
copy numbers using a linear equation derived from a standard curve which was run in 
parallel. 
 
ATP  
To quantitatively determine the amount of Adenosine TriPhosphate (ATP) in the 
supernatant, the ATPLite assay kit (Perkin Elmer; Waltham, MA) was used according to 
the manufacturers' instructions using 100 μl supernatant per reaction point. 
 
Tryptophan fluorescence excitation wavelength 
The fluorescence spectra were collected on a Fluorolog spectrofluorometer.  The 
tryptophan fluorescence of each peptide was measured at both pH5.5 and pH7.4 (30m M 
Phos and 150m M NaCl ), with and without lipid titration.
221
  The lipid stock was 
prepared with 90% POPC and 10% POPG, and the final concentration of lipid after 
titration is 200μM. The peptide concentration in each measurement was 2μM.  
 
CD measurement and thermal denaturation 
CD spectra were collected with a Jasco J-810 spectropolarimeter using a 1-nm 
step at 4 °C, at both pH5.5 and pH7.4 (30m M Phos and 150m M NaCl ).
139
 The PSPF-
EKG peptide concentration was 2 μM. The CD spectrum was obtained by averaging over 
three scans. 
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The helical CD signal at 222nm for 2μM, 4μM and 20μM was monitored as 
temperature increased from 4 °C to 96 °C at both pH5.5 and pH7.4 (30m M Phos and 
150m M NaCl ) , in a 2 °C steps.
46
 The parameters from the Gibbs-Helmholtz Equation 
were fit to the data as shown in Result 3.4.4.3. The fitting was demonstrated in the 
previous publication.
200
 
 
Size exclusion chromatography 
Size exclusion chromatography (SEC) of 100μM PSPF-EKG and 100μM PSPF-
DKG were measured by AKTA FPLC machine (GE) using a Superdex 75 column (GE) 
eluted at pH 7.4 (50 mM Tris, 150 mM NaCl) and pH 5.5 (50 mM MES, 150 mM NaCl) 
respectively, at 25°C.
46
  Four standards were used: blue dextran (2,000,000 g/mol), 
carbonic anhydrase (29,000 g/mol), cytochrome C (12,400 g/mol) and aprotinin 
(6,500g/mol). In order to test the effect of salt concentration upon peptide elution, the 
elutions of PSPF-EKG were also measured at pH 7.4 (50 mM Tris, 2M NaCl) and pH 5.5 
(50 mM MES, 2 NaCl), respectively.  
 
Sedimentation Equilibrium of Analytical Ultracentrifugation (AUC) 
Sedimentation Equilibrium of Analytical Ultracentrifugation (AUC) of 100μM 
PSPF-EKG was measured at 25 °C using a Beckman XL-I analytical ultracentrifuge at 35, 
40, 45, and 50 kRPM, at both pH 7.4 (50 mM Tris, 150 mM NaCl) and pH 5.5 (50 mM 
MES, 150 mM NaCl). The data was globally fit to a nonlinear least squares curves by 
IGOR Pro (Wave-metrics) as previously demonstrated. 
82, 139, 141, 157
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The AUC measurement of PSPF-EKG has also been measured in N-tetradecyl-
N,N dimethyl-3-ammonio-1-propanesulfonate (C-14 betaine) micelles. 17% D2O in 
buffer was used to precisely match the density of 8mM C-14 betaine micelle at pH 7.4 
(50 mM Phos, 150 mM NaCl) and 22% D2O was used for pH 5.5 (50 mM Phos, 150 mM 
NaCl). Three groups of samples were prepared as peptide:DPC molar ratios of 1:50, 
1:100, and 1:200 at both pHs. The data with three peptide/detergent ratios and four rotor 
speeds (35, 40, 45, and 50 kRPM) was globally fit to to a nonlinear least squares curves 
by IGOR Pro (Wave-metrics) as previously demonstrated. 
82, 139, 141, 157
 
 
Attenuated Total Reflection IR Spectroscopy (ATR-IR) 
ATR-IR of PSPF-EKG was measured by a Nicolet Magna IR 4700 spectrometer 
using 1 cm
−1
 resolution.
143, 144, 201
 5.0
-7
 mole PSPF-EKG in trifluoroethanol (TFE) was 
mixed with 20 fold mole of 1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine (POPC) 
and dried into a thin film on the surface of ATR Ge crystal evenly by N2 gas. The film 
was rehydrated by D2O-saturated air overnight in closed environment of D2O bath. 
During data acquisition, the polarized mirror was adjusted to 0° and 90°, creating incident 
light oriented parallel and perpendicular to the lipid normal respectively. The infrared 
spectrum of each condition was averaged over 256 scans. The dichroic ratio of 1656 cm
−1
 
amide I bond absorption is computed for parallel (0°) versus perpendicular (90°) 
polarized incident light relative to the membrane normal and has been used to calculate 
the peptide orientation as previously shown. 
143
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4.6 Contributions:  
William F DeGrado, Gevorg Grigoryan, Michael Bryan, Jason Donald and Yao 
Zhang developed the design principles; Rene Bartz, Stephen C. Beck, Nathalie Innocent, 
David Tellers and Vasant Jadhav from Merck. & Co. performed the cellular release 
assays; Michael Bryan performed Trp fluorescence, CD scan, and thermal denaturing 
assays, Yao Zhang performed thermal denaturing data analysis, SEC, AUC, ATR-FTIR 
and the related data analysis.  
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5 Chapter 5: The design and characterization of a membrane 
metalloprotein 
 
5.1 Introduction 
Despite the significant progress in understanding membrane protein folding,
14, 59, 
82, 139, 157
 the rational design of membrane proteins still remains challenging. Previous 
efforts have demonstrated successful examples of water-soluble metalloprotein design.
222-
225
 Also, the design has been further applied to ferrous-ferric redox chemistry as a protein 
scaffold and exhibited enzymatic functions.
226
 Similar metal-binding properties in the 
membrane phase have long been desired in order to design novel membrane biomaterials 
and advance our understanding of membrane protein folding.
157
  
 
Here, we present a designed membrane di-iron binding protein MDF (Membrane 
Duo Ferro). This membrane protein binds to two ferrous cations within a single site and 
forms a ferrous complex which can then be oxidized into a diferric species upon air 
oxidation. The design will contributes to our understanding of membrane protein folding. 
and provides groundwork for designing metalloenzyme that can catalyze the oxidation of 
small molecules in the membrane phase  
 
 
130 
 
5.2 Results 
The design rational focuses on three major design decisions. Firstly, a His/Glu 
chelation system was chosen as the metal-binding center, because it is commonly 
observed in natural and previously designed systems (Figure 5.1A, Table 5.1).
222, 223, 225, 
227-229
 Secondly, a four-helix bundle, which has been proven successful in natural and 
previously designed water-soluble metalloproteins,
223, 225, 227, 228, 230
 was chosen as the 
minimal catalysis scaffold for the metal binding site (Figure 5.1B), In contrast to the 
heterotetramer scaffold which is abundant in designed water-soluble metalloproteins 
(some were designed as a single chain linked by loops),
224-226
 the design of our membrane 
metalloprotein starts with a homotetramer template in order to simply the system. Each 
monomer helix contains both His and Glu residues in order to provide the necessary 
chelating side-chains. Thirdly, the majority of the backbone sequence was adopted from a 
previously successfully designed and characterized transmembrane model helix MS1 
(Table 5.1),
60
 to sidestep any complications with protein aggregation which has been 
observed in previously computationally designed membrane proteins in house. Based on 
these criteria the sequence of MDF has been generated as shown in Table 5.1.  
Table 5.1 The sequences of DFtetB, MS1 and MDF 
.  
*DFtetB is one chain of a designed water-soluble metal-binding heterotetramer.
226
 The 
chelating residues (Glu and His) have been highlighted in red 
 
Peptide   g abcdefg abcdefg abcdefg abcdefg 
DFtetB* 
MS1 
MDF 
  E LEELESE LEKILED EERHIEW LEKLEAK LEKL 
     BQLLIA VLLLIAV NLILLIA VARLRYL VG 
        KKW LLLLIAS ELIHLIL LALLRYL VG 
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Figure 5.1 Frequently observed His/Glu chelated metal system in both natural and 
designed proteins
230
 (A). Four-helix bundle scaffold for MDF (B).   
 
Designed as a membrane helix, MDF is insoluble in water but can be dissolved 
and studied in dodecylphosphocholine (DPC) detergent micelles, which mimic the 
membrane system. A variety of biophysical characterizations have been applied to MDF 
in order to understand its folding properties. The secondary structure of the apo form 
studied by circular dichroism (CD), suggests that MDF adopts an alpha-helical secondary 
structure in micelles at pH7.4 (buffer condition, same buffer in the following assays) 
(Figure 5.2A). Analytical ultracentrifugation (AUC) sedimentation was also applied to 
study the association state of MDF at pH7.4. The density of the solution was adjusted by 
D2O to precisely match that of the DPC detergent such that the sedimentation equilibrium 
was only contributed by MDF peptide component. Fitting the curve to a single molecular 
weight (MW) species fitting suggests an apparent MW for MDF of 12,500±50 (Figure 
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5.3A), indicating that a tetramer is formed by the MDF helices. Therefore MDF self-
assembles into a membrane four-helix bundle in detergent micelles.  
 
Figure 5.2 CD spectra of MDF (A) and iron-bound MDF (B) in DPC micelles. The 
spectra show that both apo and bound forms are predominantly α-helical at a 
peptide:DPC ratio of 1:25. 
 
Figure 5.3 Sedimentation equilibrium analysis of MDF (A) and Co(II)-bound MDF (B). 
in DPC micelles. The absorbance was measured at 300 nm. The single-species fitting 
sugeests a tetramer conformation for both apo and bound forms The Top of each panel 
shows the residuals of the fit. 
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Co(II) is extremely sensitive to its environment, and therefore the UV–visible 
spectrum can provide useful information on the stoichiometry of metal-binding and the 
metal-coordination environment.
225
 The molar extinction coefficient of Co(II)  increases 
as the coordination number decreases. As Co(II) was titrated into MDF, three absorption 
bands with λmax 530nm, 550nm and 600nm were observed (Figure 5.4A), presumably due 
to the cobalt ion‟s d–d transitions after coordination by the sidechains of MDF. The 
extinction coefficient at 550nm was calculated to be 460 M
−1
 cm
−1
 and is indicative of a 
hexacoordinate Co(II) complex within MDF.
225, 231
 Furthermore, a series of concentration 
of Co(II) was titrated to MDF and the absorbance at 550nm was plot as a function of 
Co(II)/MDF molar ratios (Figure 5.4B). The data fits nicely with an equilibrium model of 
two eqivalent Co(II)s binding to one MDF tetramer(Scheme 1), resulting in –log (Kd) of 
14.0. Equilibria with other binding stoichiometries have also been applied, yielding 
significantly poorer fitting quality.  
 
Figure 5.4 (A) Co(II) spectrum of MDF, (B) Titration of MDF with Co(II) 
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Scheme 1. 
Co(II)2TetramerCo(II)2Tetramer   
                                                 
2d [Co(II)][Tetramer]
Co(II)]2[Tetramer
K

  
 
The association state of MDF●2Co(II) complex, where Co(II) and MDF tetramer 
are mixed at stoichiometric ratio (2:1), has also been measured by AUC sedimentation. 
The single-species fitting indicates an apparent MW of 11,700±50 (Figure 5.3B). 
Therefore the metal-bound form remains tetrameric. Moreover, CD spectra of addition of 
Fe(II) into MDF tetramer at stoichiometry ratio (2:1) suggested an alpha-helical 
secondary structure (Figure 5.2B), indicating that Fe(II)-binding does not affect the 
secondary structure of MDF. Therefore the metal-bound form also adopts a four-helix 
bundle conformation.  
 
Finally Fe(II) has been used as a spectroscopic probe to study the kinetics of 
metal binding.
224, 226
 Since the ferrous form is rapidly oxidized into ferric form in the 
presence of ambient O2, the kinetics of diferric oxo-bridged species formation could be 
considered as the kinetics of the metal binding step. The time course of the absorbance of 
MDF tetramer upon the addition of 2 equivalents of Fe (II) was measured by UV-vis 
spectroscopy. The intensity increase at 320 nm, which results from the ligand-to-metal 
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charge transfer of the diferric oxo-bridged species, was collected.
224, 226
 The curve of the 
intensity increase at 320 nm as a function of time was fitted with the equilibrium in 
scheme 2 and resulted in a metal-binding rate of 1.6s
-1
; about 60 fold faster than the rate 
observed in the water-soluble metalloprotein (1.5min
-1
). 
 
Scheme 2. 
)(2)(2)(2
)()( 2 IIIFeTetramerIIFeTetramerTetramerIIFe
FastOSlow     
 
 
Figure 5.5 (A) Oxidation of Fe (II) in presence of MDF, (B) The time course of the 
intensity increase at 320nm was fit based on Scheme 2.   
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5.3 Conclusion and discussion  
In conclusion, we have successfully designed a membrane four-helix bundle, 
which tightly binds metals at a 2 metal cation: 1 tetramer stoichiometric ratio. Since MDF 
binds to iron cations, it allows the possibility of introducing iron-based redox reaction 
centers in the membrane phase and can serve as a template for further membrane 
metalloenzyme design.  
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5.4 Methods 
Peptide Synthesis, cleavage and purification 
The sequence of MDF is KKWLLLLIASELIHLILLALLRYLVG. The peptide 
was synthesized at a 0.1 mmole scale on RINK amide resin (Novabiochem) on a 
Symphony peptide synthesizer as previously described
139
. The resin is further cleaved in 
a mixture of trifluoroacetic acid (TFA)/water/triisopropylsilane (94/3/3) and precipitated 
with cold diethyl ether. The crude product is purified using a reverse phase HPLC (Vydac, 
C4 Column) in a gradient of solvent A (water with 0.1% TFA) and solvent B (60% 
isopropanol, 30% acetonitrile, 10% water and 0.1% TFA). 
 
Circular dichroism (CD) 
In order to prepare peptide detergent micelles, MDF and DPC were mixed in 
2,2,2-trifluoroethanol (TFE), dried under nitrogen and rehydrated with the experimental 
buffer. CD measurements of MDF were carried out in 80μM MDF and 2mM DPC at pH 
7.4 (10mM MOP and 10mM NaCl). The measurement of iron-bound form was acquired 
in a 0.1 cm quartz cell with a Jasco J-810 CD spectropolarimeter, using a 1-nm step at 
25°C.The final CD spectra of MDF were averaged over three scans  and the baseline 
(obtained by DPC in buffer) was subtracted. The CD spectra of the iron-bound form were 
collected from a sample containing 40μM iron cation, 80μM MDF and 2mM DPC, the 
mixture of which has been incubated for 12 hours prior to measurement.  
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Analytical ultracentrifugation (AUC) 
Sedimentation equilibrium experiments and data analysis were processed as 
previously demonstrated.
82, 139, 141, 157
 The samples contained 320 μM and 160 μM MDF 
respectively in 8mM DPC at pH7.4 (100mM HEPES and 100 mM NaCl). 37% D2O has 
been included in order to match the density of the detergent. The experiments were 
conducted at 25 °C using a Beckman XL-I analytical ultracentrifuge at respectively 30, 
35, 40, 48 KRPM. Data obtained were globally fitted to a nonlinear least-squares curve 
by IGOR Pro (Wavemetrics).  
 
Co (II) titration 
The spectra of Co(II) absorption were collected from 200μM MDF and 5mM 
DPC at pH7.4 (150mM MOP and 150 mM NaCl), using a Cary 300 UV spectrometer. 
CoCl2 was added to the sample and allowed to equilibrate at room temperature. Data 
obtained were fitted to scheme xx by IGOR Pro (Wavemetrics). 
 
Fe (II) binding kinetics 
The kinetics of Fe (II) binding was measured at 100μM MDF and 2.5mM DPC at 
pH7.4 (150mM MOP and 150 mM NaCl), using a Hewlett Packard model 8453 diode 
array spectrometer. The reaction was initiated by addition of Fe(II) from a stock solution 
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(10mM Fe(NH4)2SO4 and 0.01%H2SO4), reaching a final concentration of 50μM Fe(II). 
Data obtained were fit to scheme xx by IGOR Pro (Wavemetrics). 
 
5.5 Contributions 
William F. DeGrado and Yao Zhang designed MDF. Yao Zhang performed all the 
experiments and related analysis in this chapter.  
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6 Chapter 6:Conclusions and Discussions 
 
This thesis has used helix association as a model system and contributed to our 
knowledge in: 1. identifying the role of membrane protein folding in type I envelope viral 
fusion; 2. understanding the driving forces behind membrane protein folding; 3. 
designing and characterizing novel therapeutic agents.  
 
Chapter 2 introduces the importance of membrane protein folding in viral fusion, 
where I have discovered that the N-terminal hydrophobic fusion peptides of 
paramyxovirus fusion proteins form a six-helical TM bundle. This is the first 
experimental evidence that suggests the fusion peptide of type I viral fusion protein 
adopts a transmemrbane alpha helix secondary structure in lipid bilayers.  Further 
experiments show that the C-terminal membrane segment of the fusion protein strongly 
interacts with the corresponding N-terminal fusion peptide in a 1:1 ratio. All the data 
point to a cooperative folding of fusion proteins in both the membrane, in addition to the 
previous discovery about folding in the water-soluble regions, which is predicted to play 
a critical role in overcoming the energy barrier of lipid mixing between virus and host 
cell and driving viral fusion.  Based on this discovery, we proposed a novel protein-
folding-centric viral fusion model. 
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In Chapter 3, using a de novo designed membrane model peptide MS1, I have 
identified some of the key forces that drive membrane helix association in chapter 5. My 
experimental data demonstrated that as the size of apolar residue in the putative a 
position decreases (from isoleucine, to valine, to alaline, to glycine), the helix association 
affinity significantly increases, the trend of which is opposite to that in aqueous systems, 
in which hydrophobic interaction is the driving force for folding. Instead, van der Waals 
interaction appear to plays the crucial roles in bringing membrane helices together and 
small apolar residues are preferred at the helix interface. Moreover, apolar residues in the 
helix interfaces also determine the orientation of helix-helix interaction. As the apolar 
residues in the interface get smaller, the helices are able to get closer to each other, and 
the role of electrostatic interaction is significantly increased. In order to satisfy the 
dipole-dipole interaction between the backbones and stabilize the helix bundle, an anti-
parallel orientation is preferred. This is the first time that role of these two driving forces 
have been experimentally identified in membrane helix interactions.   
 
In light of the discovery in Chapter 3, we have designed a group of pH-switchable 
helix-association-based intracellular delivery agents in Chapter 4. This design has 
touched a few challenging points: 1. The designed peptide forms stable water-soluble 
helix in water-soluble system at pH7.4; 2. As the pH decreases to 5.5, which corresponds 
to the pH in endosome, the stability of water-soluble form was destabilized and the 
peptide is driven to the membrane insertion; 3. The peptide is also designed to form 
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stable TM helix bundle at pH 5.5 and lead to endosomal release. The first round of design 
chose Glu, Asp and His as the pH-dependent switch trigger. Leucine zipper has been 
selected to stabilize water-soluble form. Small residues such as Gly and Als have been 
used to stabilize TM helical interface, based on the results from Chapter 3. Furthermore, 
Lys and Arg have been screened to be water-exposure phase in both water-soluble system 
(outer-surface) and membrane system (the interior of channel). The top candidate PSPF-
EKG in the first round design has successfully induced ATP and miRNA release upon pH 
switch. Results from the following biophysical assays also point to a mechanism model 
that agrees well with the original design.  
 
Furthermore, the design and characterization of a membrane metalloprotein has 
been demonstrated in Chapter 5. This design took the self-assembly of a membrane four-
helix bundle as scaffold and introduced the metal binding (Co
2+
 and Fe
2+
) via Glu and His 
chelating. The design has been validated and can serve as a scaffold for future membrane 
metalloenzyme design.  
 
In summation, this thesis covers a wide array of diverse applications related to the 
helix-association model, from the mechanism identification of diseases systems, to the 
fundamental study of protein folding, and finally to the design of novel functions. The 
work presented here has contributed to our understanding of protein folding and explored 
the application of protein folding, in both aqueous and membrane system.  
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